Alert: Claims Focus on Alleged Misrepresentations About Weakening Veterinarian Adoption and Prescription Trends That Cost ZTS Investors $23.91 Per Share Following the Final Disclosure
, /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Zoetis Inc. (NYSE: ZTS) securities of a pending securities class action.
THE CASE: A class action seeks to recover damages for investors who purchased Zoetis securities between January 14, 2025 and May 6, 2026.
YOUR OPTIONS: You may be entitled to compensation without payment of any out-of-pocket fees. See if you can recover losses or contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.
Zoetis shares fell $23.91 per share on May 7, 2026, the fourth decline in a series of successive disclosures, after the Company admitted that veterinarian prescription trends, clinic patient volume, and pet owner price sensitivity had all deteriorated materially. Investors have until July 27, 2026 to seek lead plaintiff status.
How Companion Animal Prescriptions Drive Zoetis Revenue
An animal health company dependent on veterinarian-prescribed therapies cannot sustain revenue growth when the professionals who write those prescriptions lose confidence in core products. Zoetis' four flagship Companion Animal brands, which collectively generated approximately 70% of total revenue, each required veterinarian authorization before reaching a pet owner. That structure meant veterinarian willingness to prescribe was the single most important operational lever for the Company's financial performance.
The filing states that throughout 2025 and into 2026, veterinarian adoption trends for Librela were sharply weakening following the FDA's December 2024 safety warnings about seizures and deaths in treated dogs. Simultaneously, prescription volumes for Simparica Trio and dermatology products Apoquel and Cytopoint were eroding as lower-priced competitors from Elanco captured market share.
Alleged Prescription Growth Deterioration by the Numbers
Simparica franchise posted 17% U.S. growth in Q1 2025 on $260 million in revenue, but the lawsuit contends this trajectory was unsustainable as Elanco's Credelio Quattro offered tapeworm coverage Trio lacked at a lower price pointLibrela had reached 86% clinic penetration by May 2025, yet the action claims veterinarians were increasingly cautious about prescribing it following reports of severe neurological eventsDermatology products faced direct competition from Zenrelia, which Elanco marketed as comparable or superior to Apoquel in head-to-head studies at a lower costBy Q1 2026, the Company admitted that "share loss is being amplified by a derm market with declining patient volume in the clinic"Pet owners demonstrated "increased price sensitivity," further compressing prescription volumes across all franchisesThe parasiticides market itself was contracting, negatively impacting compliance rates and prescription refillsClinic Volume Decline and Price Sensitivity
As detailed in the action, the operational deterioration extended beyond competitive share loss. Patient volume inside veterinary clinics declined during the period, meaning fewer dogs were even being seen for the conditions Zoetis products treated. When combined with pet owners choosing lower-cost alternatives or delaying treatment altogether, the result was a compounding effect on Zoetis' prescription-dependent revenue model that management allegedly failed to disclose until May 2026.
Calculate your potential recovery or call (212) 363-7500.
"The complaint raises serious questions about whether investors received accurate information regarding the operational health of Zoetis' prescription-driven business model, particularly as veterinarian adoption trends and clinic volumes were allegedly deteriorating throughout the Class Period." -- Joseph E. Levi, Esq.
Start your claim now or contact Joseph E. Levi, Esq. at (212) 363-7500.
ABOUT LEVI & KORSINSKY, LLP -- Over the past 20 years, Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders. The firm has extensive expertise in complex securities litigation and a team of over 70 employees. For seven consecutive years, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report. Motions for lead plaintiff must be filed with the Court by July 27, 2026.
Frequently Asked Questions About the ZTS Lawsuit
Q: Who is eligible to join the ZTS investor lawsuit? A: Investors who purchased ZTS stock or securities between January 14, 2025 and May 6, 2026 and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses, not on whether you still hold the shares.
Q: How much did ZTS stock drop? A: Shares fell approximately 21.5%, a decline of $23.91 per share, after the Company disclosed significant deterioration across its core Companion Animal business and sharply reduced full-year guidance on May 7, 2026. Investors who purchased shares during the Class Period at artificially inflated prices may be entitled to compensation.
Q: What specific misstatements does the ZTS lawsuit allege? A: The complaint alleges Zoetis made materially false or misleading statements regarding the durability of its Companion Animal growth, veterinarian adoption trends, competitive positioning, and market share across its flagship product franchises during the Class Period. When the true state was revealed, the stock price declined sharply.
Q: What do ZTS investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible as a class member.
Q: What if I already sold my ZTS shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the Class Period and sold at a loss may still participate.
Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. You submit a claim form to receive your portion of recovery.
Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004 [email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
View original content to download multimedia:https://www.prnewswire.com/news-releases/lost-money-on-zoetis-inc-zts-join-class-action-suit-seeking-recovery---contact-levi--korsinsky-302808666.html
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health today announced advancements in how it helps streamline clinical review and create a simpler, faster, and more connected experience for care providers and members through Health OS.
Health OS represents a foundational shift in how we approach clinical review and utilization management - moving from fragmented, manual processes to a connected, intelligent ecosystem.” Ashok Chennuru, Chief Data and Digital Transformation Officer
Share Health OS is Elevance Health’s secure data platform designed to connect health information across electronic health records (EHRs), labs, and health information exchanges, helping support more informed and timely clinical decisions while reducing administrative burden for care providers. By connecting with healthcare data systems, including Epic’s Payer Platform, Health OS helps reduce manual steps and deliver clearer clinical insights.
“Health OS represents a foundational shift in how we approach clinical review and utilization management - moving from fragmented, manual processes to a connected, intelligent ecosystem,” said Ashok Chennuru, Chief Data and Digital Transformation Officer at Elevance Health. “We are enabling faster decisions, reducing administrative burden, and improving the overall care experience by applying advanced analytics and embedding data-driven insights directly into workflows between care providers, payers, and other partners.”
Elevance Health was the first to collaborate with Epic in leveraging the Epic Payer Platform in addressing inpatient concurrent reviews, where payers and providers work together to review care plans during a patient’s hospital stay. These reviews help support appropriate treatment and length-of-stay decisions but have historically relied on manual submission of clinical documentation, often resulting in delays, incomplete information, and additional administrative work.
Early results from health systems using Health OS-enabled workflows demonstrate meaningful improvements:
A 61% reduction in prior authorization denials due to insufficient clinical information Nearly 60% fewer cases designated pending because of the need for additional information Up to a 51% reduction in follow-up reviews, including appeals and peer-to-peer discussions, driven by more complete information upfront Approximately 15 minutes of administrative time saved per case with some health systems Care providers report a more transparent and efficient process, with fewer documentation requests, faster alignment on care decisions, and more time to focus on patient care Health OS is also transforming prior authorization through electronic prior authorization for medical services by making it part of provider workflows and allowing information to be appropriately and securely shared back and forth between providers and the health plan. This significantly reduces reliance on phone, fax, and paper submissions, while improving speed and consistency.
With more than 30 health systems actively participating in Elevance Health’s program for electronic prior authorization for medical services, results highlight the impact of this approach:
More than 250,000 prior authorization requests for medical services processed in 2026 through end of April Of these, more than 42% of decisions completed in one minute or less For providers, this means reduced administrative burden and a more intuitive, streamlined experience that aligns with existing workflows. For members, it translates to faster access to approved treatments and a more predictable care journey.
“Much of the waste and complexity in healthcare could be reduced by simply making the right information available to the right stakeholders,” said Alan Hutchison, Vice President at Epic. “Through our work with Elevance Health, Epic’s Payer Platform has enabled meaningful reductions in administrative burden with measurable reductions in denials, peer-to-peer reviews, and appeals. This means less work for providers and faster access to care for patients.”
Elevance Health is focused on expanding its capabilities, advancing a future where utilization management is faster, simpler, and more aligned with patient care. Health OS reflects Elevance Health’s broader commitment to simplifying the healthcare experience for consumers and helping to improve health outcomes.
About Elevance Health
Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health’s companies serve approximately 105 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.
TJX (TJX - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Over the past month, shares of this parent of T.J. Maxx, Marshalls and other stores have returned +3.4%, compared to the Zacks S&P 500 composite's -1.3% change. During this period, the Zacks Retail - Discount Stores industry, which TJX falls in, has lost 1.9%. The key question now is: What could be the stock's future direction?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current quarter, TJX is expected to post earnings of $1.17 per share, indicating a change of +6.4% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.1% over the last 30 days.
The consensus earnings estimate of $5.17 for the current fiscal year indicates a year-over-year change of +9.3%. This estimate has changed +0.3% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $5.67 indicates a change of +9.7% from what TJX is expected to report a year ago. Over the past month, the estimate has changed +0.5%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, TJX is rated Zacks Rank #2 (Buy).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
In the case of TJX, the consensus sales estimate of $15.12 billion for the current quarter points to a year-over-year change of +5%. The $63.9 billion and $67.42 billion estimates for the current and next fiscal years indicate changes of +5.9% and +5.5%, respectively.
Last Reported Results and Surprise HistoryTJX reported revenues of $14.32 billion in the last reported quarter, representing a year-over-year change of +9.2%. EPS of $1.19 for the same period compares with $0.92 a year ago.
Compared to the Zacks Consensus Estimate of $14 billion, the reported revenues represent a surprise of +2.32%. The EPS surprise was +17.82%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
TJX is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about TJX. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.
VALE S.A. (VALE - Free Report) closed the most recent trading day at $15.31, moving -2.55% from the previous trading session. The stock trailed the S&P 500, which registered a daily loss of 1.44%. Meanwhile, the Dow lost 0.09%, and the Nasdaq, a tech-heavy index, lost 2.22%.
Shares of the company witnessed a loss of 4.67% over the previous month, trailing the performance of the Basic Materials sector with its loss of 0.5%, and the S&P 500's gain of 0.08%.
The upcoming earnings release of VALE S.A. will be of great interest to investors. The company is expected to report EPS of $0.51, up 2% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $10.65 billion, reflecting a 21% rise from the equivalent quarter last year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $2.15 per share and a revenue of $41.73 billion, indicating changes of +18.13% and +8.65%, respectively, from the former year.
Any recent changes to analyst estimates for VALE S.A. should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 1.51% increase. At present, VALE S.A. boasts a Zacks Rank of #3 (Hold).
Looking at its valuation, VALE S.A. is holding a Forward P/E ratio of 7.31. This represents a discount compared to its industry average Forward P/E of 8.29.
The Mining - Iron industry is part of the Basic Materials sector. Currently, this industry holds a Zacks Industry Rank of 28, positioning it in the top 12% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
We know earnings results are vital, but how a company performs compared to bottom line expectations can be even more important when it comes to stock prices, especially in the near-term. This means that investors might want to take advantage of these earnings surprises.
The ability to identify stocks that are likely to top quarterly earnings expectations can be profitable, but it's no simple task. Here at Zacks, our Earnings ESP filter helps make things easier.
The Zacks Earnings ESP, ExplainedThe Zacks Earnings ESP, or Expected Surprise Prediction, aims to find earnings surprises by focusing on the most recent analyst revisions. The basic premise is that if an analyst reevaluates their earnings estimate ahead of an earnings release, it means they likely have new information that could possibly be more accurate.
With this in mind, the Expected Surprise Prediction compares the Most Accurate Estimate (being the most recent) against the overall Zacks Consensus Estimate. The percentage difference provides the ESP figure. The system also utilizes our core Zacks Rank to provide a stronger system for identifying stocks that might beat their next quarterly earnings estimate and possibly see the stock price climb.
When we join a positive earnings ESP with a Zacks Rank #3 (Hold) or stronger, stocks posted a positive bottom-line surprise 70% of the time. Plus, this system saw investors produce roughly 28% annual returns on average, according to our 10 year backtest.
Most stocks, about 60%, fall into the #3 (Hold) category, and they are expected to perform in-line with the broader market. Stocks with a #2 (Buy) and #1 (Strong Buy) rating, or the top 15% and top 5% of stocks, respectively, should outperform the market, with Strong Buy stocks outperforming more than any other rank.
Should You Consider IBM?Now that we understand what the ESP is and how beneficial it can be, let's dive into a stock that currently fits the bill. IBM (IBM - Free Report) earns a #2 (Buy) right now and its Most Accurate Estimate sits at $3.06 a share, just 28 days from its upcoming earnings release on July 22, 2026.
By taking the percentage difference between the $3.06 Most Accurate Estimate and the $2.96 Zacks Consensus Estimate, IBM has an Earnings ESP of +3.53%. Investors should also know that IBM is one of a large group of stocks with positive ESPs. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
IBM is just one of a large group of Computer and Technology stocks with a positive ESP figure. Western Digital (WDC - Free Report) is another qualifying stock you may want to consider.
Slated to report earnings on July 29, 2026, Western Digital holds a #1 (Strong Buy) ranking on the Zacks Rank, and its Most Accurate Estimate is $3.53 a share 35 days from its next quarterly update.
The Zacks Consensus Estimate for Western Digital is $3.32, and when you take the percentage difference between that number and its Most Accurate Estimate, you get the Earnings ESP figure of +6.20%.
IBM and WDC's positive ESP metrics may signal that a positive earnings surprise for both stocks is on the horizon.
Find Stocks to Buy or Sell Before They're ReportedUse the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>
Yum! Brands (YUM +0.22%) is burning the pizza. The company is selling Pizza Hut in two transactions. First, Pizza Hut outside of mainland China will go to LongRange Capital, a private equity firm. Secondly, Pizza Hut in China will be sold to Yum China. All told, Yum! Brands will net about $2.3 billion from the sales.
Today's Change
(
0.22
%) $
0.33
Current Price
$
151.93
The $2.3 billion is an immediate win for the balance sheet. In theory, the plan to sell Pizza Hut and focus on growth opportunities within KFC and Taco Bell is a good one. Both KFC and Taco Bell have healthier unit economics and clearer paths to expanding their global footprint.
Image source: Getty Images.
Yet the entire plan hinges on consumer choices and discretionary spending. Americans' wallets are tightening and leaning toward greater value and healthier choices. Yum!'s growth assumptions reflect a level of optimism and execution that may not fully be realized. U.S. consumer debt reached an all-time high this year at $18.8 trillion. Inflation and fuel prices ticking upward over a prolonged period do not bode well for fast-food or fast-casual restaurants, either.
The sale of Pizza Hut is smart and makes the company leaner and better positioned to reward shareholders. Yum! authorized a $4 billion share buyback. The stock has been largely muted year to date, up less than 1%. If macroeconomic conditions improve, I'll be more bullish. Until then, investors should be cautiously optimistic.
Catie Hogan has no position in any of the stocks mentioned. The Motley Fool recommends Yum! Brands. The Motley Fool has a disclosure policy.
Shares of Best Buy BBY have declined following the announcement that Matt Bilunas, the company's Chief Financial and Strategy Officer, will depart at the end of July. This marks a significant leadership transition as Jason Bonfig is set to take over as CEO on November 1. Investors are concerned about the timing, as the company navigates a leadership change while facing challenges such as cautious consumer spending and margin pressures.
Leadership Setup: Bilunas has been with BBY for 20 years, overseeing finance, strategy, procurement, financial services, real estate, and omnichannel operations. His departure represents a broader change than a typical CFO transition. Transition Risk: Best Buy is engaging an external search firm to find a successor with prior CFO experience. Current CEO Corie Barry, a former CFO herself, will provide financial oversight during the transition if necessary. Operating Momentum: The company's recent performance has shown improvement, with better-than-expected Q1 profitability and eight consecutive quarters of positive computing comparisons. Margin Framework: For FY27, Best Buy anticipates a gross profit rate improvement of about 30 basis points, supported by initiatives like Best Buy Ads and U.S. Marketplace, although core product margins are under pressure from promotional activities. Demand Friction: BBY is encountering a mixed consumer-electronics market, with value-focused shoppers and softness in home theater and appliances, despite some strengths in certain categories. Capital Returns: The company has maintained its quarterly dividend of $0.96 and plans approximately $300 million in share repurchases for FY27, indicating that the leadership transition has not altered its capital-return strategy.The key takeaway is that while BBY's operational plan appears stable, the departure of the CFO adds execution and communication risks during this critical CEO transition. Investors are particularly attentive as the company manages multiple challenges, including a fragile consumer-electronics recovery and uncertainties in component costs and pricing. The transition does not inherently signal operational issues, especially with Barry's oversight and Bonfig's involvement in the company's digital strategy. However, the urgency for a credible successor announcement increases, and positive sentiment may hinge on a swift CFO appointment and continued operational stability.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
As the exclusive national retailer, Best Buy brings next-generation TV technology from Samsung, Sony, LG, TCL and Hisense to stores
MINNEAPOLIS--(BUSINESS WIRE)--The most significant advancement in TV technology in more than a decade is now available at Best Buy stores nationwide. Through exclusive partnerships with Samsung, Sony, LG, TCL and Hisense, Best Buy is the only national retailer where customers can shop RGB LED TVs and see color and brightness never before possible, from anywhere in the room.
The arrival of RGB LED TV comes at an important moment for customers, as more than 48 million televisions were purchased in 2020.1 With most TVs being replaced every five to seven years, millions of households are beginning to consider their next TV upgrade. To get ready, Best Buy trained and certified more than 15,000 Blue Shirts on the new technology, in partnership with the leading home theater brands.
Best Buy is also creating a seamless end-to-end experience for customers who buy a new RGB LED TV. Customers will get free delivery and installation, including mounting, as well as free haul-away of their current TV with most RGB LED TV purchases.
“RGB LED is the biggest leap in TV technology since OLED arrived in 2013. It is not just a spec change — the colors are physically produced differently, and it’s something you’ll notice immediately,” said Jason Bonfig, incoming CEO and chief customer, product and fulfillment officer at Best Buy. “As customers are ready for a new TV, we’re ready to show them Best Buy is the best place to experience RGB LED TVs."
Shop and experience RGB LED TVs at Best Buy
As shoppers begin to upgrade and replace their TVs, Best Buy has built an experience for its customers they won’t find anywhere else — bringing together the industry’s leading RGB LED TV brands, thousands of specially-trained experts across the country, free delivery and installation, and more.
Exclusive national retail partner: Best Buy is the only national retailer where customers can experience and shop RGB LED TVs from Samsung, Sony, LG, TCL and Hisense — in stores, on the Best Buy App and on BestBuy.com. Experience RGB LED TVs in store: Customers can find RGB LED TVs now on display in nearly every Best Buy store, with screen sizes starting at 50 inches and extending into Best Buy’s XXL TV lineup, including 116-inch displays. Expert support: In partnership with leading RGB LED TV brands, Best Buy has trained and certified more than 15,000 Blue Shirts nationwide on the new technology to help customers find the right TV for their home. Easy upgrade: Best Buy customers can receive free delivery, installation and mounting, in addition to haul-away of their old TV, with all RGB LED TV purchases — making it easier than ever to upgrade. RGB LED technology: Color and brightness never before possible
RGB LED is more than the latest TV technology — it’s a new standard for the viewing experience. By combining thousands of precision dimming zones with dedicated red, green and blue LEDs, RGB LED TVs deliver more lifelike color, higher brightness and enhanced clarity for a truly immersive experience.
Lifelike color: RGB LED TVs can produce nearly 76% of colors the human eye can see — unlocking richer, more accurate and lifelike images customers don’t experience on current TVs. Brightness: RGB LED TVs are the brightest TVs on the market. Independent control of red, green and blue LEDs enables more precise brightness, creating deeper contrast and greater dynamic range. Wide viewing angles: Virtually every seat in the room, from any angle, will get the same excellent picture quality, color and brightness. Clarity: Advanced processing uses AI upscaling that enhances color and content for a sharper, more detailed viewing experience. 1Circana, LLC, Retail Tracking Service, Unit Sales, 52 WE Jan 9, 2021
About Best Buy
Best Buy (NYSE: BBY) is the world's largest specialty consumer electronics retailer. Our purpose is to enrich lives through technology, which we do by providing our customers a unique mix of advice, products and services in our stores, online, and in homes. Our expert associates advise customers on our curated assortment of the latest, name-brand technology, while our highly trained services teams help with designs, consultations, delivery, installation, tech support and repair. We are a leader in corporate responsibility and sustainability issues, including through the Best Buy Foundation's nationwide Best Buy Teen Tech Center® network and the significant role we play in the circular economy through repair, trade-in and recycling programs. We generated $41.7 billion of revenue in fiscal 2026, operate more than 1,000 retail stores in North America, and have more than 80,000 employees. For more information, visit corporate.bestbuy.com and investors.bestbuy.com.
Toyota Motor Corporation faces profit pressure from U.S. tariffs and a $5.6B revenue miss, prompting a CEO change to prioritize financial discipline. TM is intensifying U.S. production, focusing on hybrid electric vehicles (HEVs) as a transitional electrification strategy, and expanding value chain revenues. Despite a 3.5% dividend yield and Seeking Alpha's F-grade for dividend safety, TM's robust A+ rating, $93B net cash, and low 9.1x P/E support dividend stability.
Vancouver, British Columbia--(Newsfile Corp. - June 24, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced a strategic partnership with SportifEye Optics ("SportifEye"), a cutting-edge, full-service optical laboratory and VSP®-Authorized Lab based in Southern California, to support the production and commercialization of its SpectraGuard lens technology in the United States.
The Company's proprietary SpectraGuard technology is a patented nano particle optical lens treatment that provides a new standard of eye protection for the general eyewear market. The patented technology is designed to provide eye protection from bright sunlight by filtering 100% of ultraviolet (UV) light and up to 90% of wavelengths between 400-600 nm, including blue light, while preserving natural visual clarity and color perception.[1] These performance specifications reflect the Company's previously disclosed intended use claim for SPECTRAGUARD™, as accepted by the FDA in connection with the Company's Class I exempt medical device registration.
SportifEye is uniquely positioned as a specialist optical laboratory with deep expertise in sport, safety, and performance eyewear, including customized prescriptions for high-wrap frames and compliance with ANSI, Ballistic, EN166, and MIL-Spec requirements. This partnership extends Rise's lab network into a high-value market segment where advanced optical performance and protection are critical, combining direct commercial demand generation by Rise with integrated manufacturing and distribution through SportifEye, allowing for efficient scaling without significant capital investment in production infrastructure.
Under the partnership, SportifEye will:
Manufacture SPECTRAGUARD™ lenses on behalf of Rise Distribute SPECTRAGUARD™ lenses through its existing network of eye care professionals (ECPs) and retail partners Support fulfillment of Rise-generated demand across the sport, safety, and performance eyewear segment, enabling scalable production as the Company expands its commercial footprint Erik Ritchie, Chief Commercial Officer of Rise Nano Optics, commented, "Our partnership with SportifEye represents an important expansion of our lab network into the sport and performance eyewear segment. SportifEye's technical expertise in high-wrap frames and specialty lens manufacturing, combined with their established ECP and retail relationships, makes them an ideal partner to bring SpectraGuard to athletes, outdoor enthusiasts, and individuals who demand the highest standard of optical protection. This partnership reinforces our phased commercialization strategy and our commitment to building a distributed lab network capable of serving multiple channels and customer segments across the United States."
Thomas Pfeiffer, Chief Executive Officer of SportifEye Optics commented, "We're excited to partner with Rise to introduce SpectraGuard to the independent optical channel in the United States. We believe SpectraGuard represents a meaningful advancement in light management offering exceptional sun protection while significantly enhancing blue light filtering in photochromic lenses. We believe this technology gives independent eye care professionals and eyewear brands a compelling new way to differentiate themselves and better serve the evolving needs of today's patients and consumers."
This is the Company's second optical lab partnership in the United States and represents continued execution of its North American commercialization strategy. The Company intends to replicate this model by aligning with additional independent laboratories, creating a distributed manufacturing and fulfillment ecosystem capable of supporting increasing demand as adoption of SpectraGuard lenses grows. By leveraging established lab infrastructure and industry relationships, Rise is positioned to scale efficiently without significant capital investment, while maintaining flexibility across multiple distribution channels.
The partnership is governed by an Authorized Optical Laboratory Agreement between Rise Nano Optics, Inc., the Company's wholly-owned U.S. subsidiary incorporated in Delaware, and SportifEye, Inc., executed and effective as of May 12, 2026. The agreement is non-exclusive and continues until terminated by either party,
As part of its global strategy, Rise will continue to establish a network of optical lab partners, clinical channel partnerships as well as broader brand integrations across North America and internationally.
About SportifEye Optics
SportifEye Optics is a cutting-edge, full-service optical laboratory based in Southern California, specializing in sport, safety, and performance eyewear. The company is known for its expertise in customized prescriptions for high-wrap frames and compliance with ANSI, Ballistic, EN166, and MIL-Spec requirements, supported by industry veterans with over 40 years of experience. For more information visit: https://sportifeye.com/.
About Rise
Rise Nano Optics Ltd. is a health technology company specializing in advanced nanotechnology lens solutions designed to selectively filter high-energy visible light wavelengths. Its patented SPECTRAGUARD™ technology integrates nanomaterial innovation, ophthalmic research, and scalable optical engineering to serve both clinical and consumer eyewear markets globally.
For more information, visit: www.risenanooptics.com.
Forward‐Looking Statements
This news release contains forward-looking statements relating to the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the trading of the Common Shares and the future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations are risks detailed from time to time in the filings made by the Company with securities regulations.
Readers are cautioned that that forward-looking information is not based on historical facts but instead reflect the Company's management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the approval of the CSE to commence trading of the Common Shares, the demand for the Company's products and technology, including SPECTRAGUARD™, the expansion of the Company's business partnerships and the success of the Company's patents and intellectual property, whether future or current. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
[1] See Rise news release dated March 23, 2026, "Rise Nano Optics Announces FDA Registration and Class I Device Classification for SPECTRAGUARD™ Nano-Optic Lens Technology."
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/302574
Source: Rise Nano Optics Ltd.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
The brand expands nationwide distribution on Amazon, delivering a waterless, rapid-dissolve 50 mg caffeine powder built for active, on-the-go lifestyles.
ESTERO, FL / ACCESS Newswire / June 24, 2026 / Aspire Biopharma Holdings, Inc.'s (Nasdaq:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC today announced the nationwide Amazon launch of its innovative BUZZ BOMB™ 50mg caffeine stick packs.
This e-commerce expansion represents a significant milestone in BUZZ BOMB™'s mission to provide clean, accessible energy to athletes, professionals, fitness enthusiasts, and busy individuals. By launching on the U.S. Amazon store, the brand scales its retail footprint to meet the growing consumer demand for fast-acting, convenient wellness products.
A Smarter Way to Energize
BUZZ BOMB™ disrupts the traditional energy market by eliminating the need for bulky cans, sugary liquids, or hard-to-swallow pills. Delivered in pre-measured, single-serving stick packs, the flavored dry powder dissolves directly under the tongue (sublingually). This advanced method provides a rapid energy boost without the liquid volume, crash, or artificial additives commonly found in standard energy drinks, coffees, and sodas.
"Modern consumers demand clean, efficient, and highly portable energy solutions that align with an active lifestyle," said Kraig Higginson, CEO of Aspire. "Launching on Amazon allows us to deliver BUZZ BOMB™ directly to a massive, health-conscious audience via a marketplace they already rely on. We are thrilled to make our innovative caffeine product accessible to millions of households nationwide."
BUZZ BOMB™ Key Benefits:
Easy Delivery: Dissolves instantly under the tongue with no water required.
On-the-Go Convenience: Slim, pocket-sized stick packs fit effortlessly into gym bags, pockets, or desks.
Controlled Dosage: Each stick pack provides a precise 50 mg serving of clean caffeine.
Health-Conscious: Formulated as a sleek alternative to high-calorie, jitter-inducing energy beverages.
BUZZ BOMB™ stick packs are now available for purchase in Variety Pack, Mixed Berry and Mango flavors in 20-X packets on Amazon. To shop the collection or learn more, visit https://www.amazon.com/BUZZ-BOMB-Packets-Caffeine-Variety/dp/B0H2G5Y55G/.
To learn more about BUZZ BOMB™, or purchase products online directly, please visit https://buzzbombcaffeine.com or follows us on social media here:
Facebook
Instagram
TikTok
BUZZ BOMB™ Caffeine Products
BUZZ BOMB™ features 50mg of caffeine and is currently offered in four delicious flavors: Tropical Fruit, Mixed Berry, Peach Mango, and Coffee Mocha. Designed for athletes, professionals, and the everyday person needing a rapid boost, BUZZ BOMB™ provides a precise serving of caffeine in easy-to-use single serving stick packs.
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma delivers supplements to the body rapidly and precisely.
For more information, please visit www.aspirebiolabs.com.
This press release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the "safe harbor" provisions created by those laws. Aspire's forward-looking statements include, but are not limited to, statements regarding our or our management team's expectations, hopes, beliefs, intentions or strategies regarding our future operations. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "contemplate," "continue," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "will," "would," and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements represent our views as of the date of this press release and involve a number of judgments, risks and uncertainties. We anticipate that subsequent events and developments will cause our views to change. We undertake no obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ in our drug or supplement offerings include general market conditions, whether clinical trials demonstrate the efficacy and safety of our drug candidates to the satisfaction of regulatory authorities, or do not otherwise produce positive results which may cause us to incur additional costs or experience delays in completing, or ultimately be unable to complete the development and commercialization of our drug candidates; the clinical results for our drug candidates, which may not support further development or marketing approval; actions of regulatory agencies, which may affect the initiation, timing and progress of
clinical trials and marketing approval; our ability to achieve commercial success for our drug or supplement candidates, if approved; our limited operating history and our ability to obtain additional funding for operations and to complete the development and commercialization of our product candidates, and other risks and uncertainties set forth in "Risk Factors" in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and you are cautioned not to rely unduly upon these statements. All information in this press release is as of the date of this press release. The information contained in any website referenced herein is not, and shall not be deemed to be, part of or incorporated into this press release.
Toyota Motor Corporation (TM - Free Report) is expanding its zero-emission vehicle (ZEV) portfolio in 2026, reinforcing its position as a full-line automaker with a broader lineup of battery-electric vehicles (BEVs) and plug-in hybrid electric vehicles (PHEVs). To showcase its latest electrified offerings, Toyota Canada hosted the “Unplug and Drive” event in Quebec from June 2-5, where automotive journalists from across Canada tested the company’s newest electrified models.
Quebec, which accounts for more than one-third of Toyota’s BEV and PHEV sales in Canada this year, was selected as the venue due to its strong adoption of ZEVs. Electrified vehicles, including hybrids, plug-in hybrids and BEVs, have represented 64% of Toyota’s total Canadian sales in 2026.
Per Steve Pilkey, vice president of Sales and Marketing at Toyota Canada, the company’s multi-pathway electrification strategy gives consumers a range of powertrain choices. Toyota has put more than 660,000 electrified vehicles on Canadian roads and expects to offer 21 electrified models by the end of 2026, including hybrids, plug-in hybrids and four battery-electric vehicles.
Toyota has been a leader in vehicle electrification for nearly three decades. Its journey began with the RAV4 EV in 1996, followed by the launch of the Prius hybrid in 1997, the Prius Plug-in Hybrid in 2012, the RAV4 Prime in 2021 and the bZ4X in 2023. Globally, Toyota has sold more than 35 million electrified vehicles and remains Canada’s top seller of electrified models. At the event, journalists evaluated five key models, including the 2026 Toyota C-HR, 2026 Toyota bZ, 2026 Toyota bZ Woodland, 2026 Toyota RAV4 Plug-in Hybrid and 2026 Toyota Prius Plug-in Hybrid Nightshade, showcasing the breadth of Toyota’s ZEV lineup.
The 2026 Toyota C-HR is an all-new BEV that combines sporty styling, engaging performance and practicality. Available in three trims starting at $44,900, it offers up to 496 km of range in front-wheel-drive form or up to 338 horsepower with all-wheel drive.
The 2026 Toyota bZ is Toyota’s refreshed compact electric SUV, featuring updated styling, increased performance, faster charging and up to 486 km of range. Offered in three trims, pricing starts at $45,990.
The 2026 Toyota bZ Woodland is designed for adventure-oriented drivers. This new electric SUV delivers up to 452 km of range, 375 horsepower, standard all-wheel drive, a 3,500-pound towing capacity and generous cargo space. Pricing starts at $59,900.
The 2026 Toyota RAV4 Plug-in Hybrid is the latest version of Canada’s best-selling passenger vehicle and uses Toyota’s sixth-generation plug-in hybrid system, producing 324 horsepower and up to 89 km of all-electric driving range. Available in four trims, including the new GR SPORT variant, pricing starts at $48,750.
The 2026 Toyota Prius Plug-in Hybrid Nightshade is a special edition that adds distinctive black styling elements while maintaining up to 72 km of electric range and a combined fuel efficiency of 4.5 L/100 km. The Prius PHEV lineup starts at $40,050.
Participants also previewed the all-new 2027 Toyota Highlander EV, Toyota’s first three-row electric SUV and the company’s first mass-market BEV built in North America. Available in both front- and all-wheel-drive configurations, it is expected to offer up to 511 km of range and will arrive at Canadian dealerships later this year.
Toyota currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the auto space are Geely Automobile Holdings Limited (GELHY - Free Report) , Douglas Dynamics, Inc. (PLOW - Free Report) and Garrett Motion Inc. (GTX - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for GELHY’s 2026 sales and earnings implies year-over-year growth of 77.1% and 40.3%, respectively. The EPS estimate for 2026 and 2027 has improved 18 cents and 7 cents, respectively, over the past 30 days.
The Zacks Consensus Estimate for PLOW’s 2026 sales and earnings implies year-over-year growth of 16.7% and 3.9%, respectively. The EPS estimate for 2026 and 2027 has improved 39 cents and 29 cents, respectively, over the past 60 days.
The Zacks Consensus Estimate for GTX’s 2026 sales and earnings implies year-over-year growth of 5.6% and 20.4%, respectively. The EPS estimate for 2026 has improved 12 cents over the past 60 days, while the EPS estimate for 2027 has improved a penny over the past 30 days.
DETROIT – Toyota Motor is notably gaining on America's largest automaker, General Motors, in U.S. sales as hybrids get more popular and all-electric vehicles sputter.
The Japanese automaker is expected to report a nearly 1% increase in U.S. sales through the first half of this year to 1.25 million vehicles, while GM is projected to be down 7.2% to 1.33 million, according to a new forecast released Wednesday by Cox Automotive.
"At these rates, and what we're seeing right now in the selling rates, GM may be looking over their shoulder here when we get to the year's end, that Toyota could potentially overtake them as the top selling manufacturer here in the U.S. market," Charlie Chesbrough, senior economist and senior director of industry insights at Cox Automotive, said during a media event.
Chesbrough said he isn't yet forecasting that Toyota would top GM, but he said the trends are "concerning for General Motors."
The expected 83,255 difference in vehicle sales through the first half of the year would be the narrowest between the two automakers since Toyota topped GM in U.S. sales for the first time ever in 2021. That was in part the result of supply chain issues during the coronavirus pandemic.
At that time, Toyota chair and company scion Akio Toyoda said he did a "happy dance" when learning of the win, but executives said the company didn't expect it to be sustainable. Other than that year, GM has been the top-selling automaker in the U.S. since 1931, according to industry data.
Toyota's gains come as the automaker has continued to roll out new models, including all-electric vehicles, while continuing to double down on its hybrid vehicles, where it's been a leader for decades.
GM, meanwhile, heavily invested in all-electric vehicles instead of hybrids, many times referring to them as a transitional technology. The Detroit automaker's sole hybrid is a Corvette, while it offers a full lineup of EVs for luxury brand Cadillac as well as many models for other brands.
"The story is hybrids are having their moment," said Stephanie Valdez Streaty, Cox director of industry insights, during the Wednesday event.
Cox expects overall U.S. new vehicle sales to be down 3% through the first half of the year compared to last year, including a 0.5% decline during the second quarter.
The firm forecasts EV sales down 23.3% during first half this year. Hybrid sales, meanwhile, are projected to be up about 10%.
Honda, Volkswagen and Stellantis are expected to post sales gains for the second quarter, while Cox is forecasting the largest sales declines for Tesla, Ford Motor and GM.
Paramount logo is seen in this illustration taken December 8, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
CompaniesBRUSSELS, June 24 (Reuters) - Paramount Skydance Corp (PSKY.O), opens new tab is prepared to divest its film distribution joint venture with Universal Pictures to address EU antitrust concerns about its $110 billion acquisition of Warner Bros Discovery (WBD.O), opens new tab, a person familiar with the matter said on Wednesday.
The offer, which follows a meeting with the European Union's antitrust regulators on Tuesday, will be submitted next Tuesday, the person said.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
That would extend the European Commission's preliminary July 7 deadline for the review by 10 working days to July 21.
Reuters exclusively reported in February that the deal would easily secure EU approval, with Paramount willing to sell minor channels such as its children's brands if required. This is now off the table as there were no issues on that front, the source said.
Divesting the film distribution joint venture with Universal Pictures could ease worries expressed by European cinema operators.
A spokesperson for Paramount said the company does not comment on ongoing regulatory proceedings.
The deal is also being assessed in a separate proceeding under the EU Foreign Subsidies Regulation, because Saudi Arabia's Public Investment Fund, Abu Dhabi's L'imad Holding Company and the Qatar Investment Authority are bankrolling the bid. Paramount is expected to win unconditional approval for this.
The U.S. Justice Department cleared the acquisition last week, saying it was unlikely to harm competition or consumers.
California, New York and other U.S. states are preparing a lawsuit to block the deal, sources familiar with the matter have told Reuters.
Reporting by Foo Yun Chee, editing by Milla Nissi-Prussak
Our Standards: The Thomson Reuters Trust Principles., opens new tab
An agenda-setting and market-moving journalist, Foo Yun Chee is a 21-year veteran at Reuters. Her stories on high profile mergers have pushed up the European telecoms index, lifted companies' shares and helped investors decide on their next move. Her knowledge and experience of European antitrust laws and developments helped her break stories on Microsoft, Google, Amazon, Meta and Apple, numerous market-moving mergers and antitrust investigations. She has previously reported on Greek politics and companies, when Greece's entry into the eurozone meant it punched above its weight on the international stage, as well as on Dutch corporate giants and the quirks of Dutch society and culture that never fail to charm readers.
Paramount Skydance is bracing for opposition to its $81 billion takeover of Warner Bros. Discovery – expecting that a duo of left-wing attorneys general will argue the tie-up violates antitrust laws that are allegedly being ignored by the White House, On The Money has learned.
Executives at the media giant run by David Ellison and his father, the mega billionaire Trump-friend Larry Ellison, “wake up every day thinking a lawsuit is being filed” by California AG Rob Bonta, New York’s Tish James and possibly a handful of other state AGs, according to a person with knowledge of the matter.
A quirk in US antitrust law allows states in some cases to override DOJ decisions, particularly if the state is big enough where the companies have significant business interests. California, for all of its woes with businesses exiting the state, is still nominally the home of the entertainment industry. New York, left-wing warts and all, remains the financial capital of the country.
Paramount Skydance executives are bracing for legal challenges by state attorneys general to its $81 billion takeover of Warner Bros. Discovery. Getty Images
Paramount Skydance expects that a duo of left-wing attorneys general will argue the tie-up violates antitrust laws that are allegedly being ignored by the White House, On The Money has learned. REUTERS People at Paramount Skydance expect a joint lawsuit, with California taking the lead given it’s the headquarters of Hollywood, where a coalition of actors, studio types and left-wing activists have opposed the deal on the grounds that it will lead to fewer jobs. There’s also the fact that the Ellisons are seen as friendly to Trump, whom West Coast elites despise.
I am told the Ellisons are ready to play a long game in the courts and win on the merits. The delay, however, will be costly. They believe a swift merger approval will lead to savings and eventually more jobs, more movies, and more money for the Hollywood lefties who are opposing the deal. A delay will likely lead to cutbacks in all of the above.
Reps for Bonta had no comment, while those for James had no immediate comment. A Paramount Skydance rep had no comment.
Both New York and California have launched investigations into the deal, as On The Money has reported. After Trump’s antitrust cops at the DOJ greenlit the deal on a federal level last week, Bonta appeared to signal his intentions by calling the move “shameless.” James has spoken specifically about the deal, but she uses language employed by deal critics about antitrust concerns that emerge from such large mergers.
People inside Paramount Skydance believe such concerns are non-existent, and they have a good point. The biggest overlap in the $81 billion combo is that it combines two large studios, Warner and Paramount, which both face intense competitive pressures.
California Attorney General Rob Bonta called the Trump administration’s approval of Paramount Skydance’s acquisition of Warner Bros. Discovery “shameless.” REUTERS Given the difficult economics of the business, the merger will likely save jobs. Before deal talk began last year, Warner Bros. Discovery was languishing despite producing a slew of hit movies. The company has been culling jobs since the 2022 merger of the ailing Warner Media with Discovery under CEO David Zaslav.
The company was grappling with huge amounts of debt, cord cutting and difficulty in making HBO Max profitable. That’s before Zas started a bidding war for the company. The $31-a-share deal the Ellisons reached with him was a significant premium to WBD’s price of around $8 before bidding began in the summer – a sign that Wall Street had previously believed the company’s future as a standalone entity was bleak.
So without a strong antitrust argument, what do Bonta and James have, exactly?
David Ellison, CEO of Paramount Skydance, speaks at CinemaCon. Chris Pizzello/Invision/AP The answer: Politics and bad blood.
The Ellisons are looking to move programming and news to the middle and away from the leftism that has permeated CBS, now a subsidiary of Paramount; and CNN, which will also be theirs if the deal is approved.
James has long been a Trump antagonist, including her infamous and petty lawsuit claiming Trump and his real estate business, the Trump Organization, inflated the value of Trump Tower in Manhattan on a loan application, eliding the fact that the loan was paid back and the bank did its own evaluation.
A lefty New York state judge initially ruled in favor of the AG and imposed a $450 million penalty on Trump, but the ruling was later overturned. James is appealing, but she faces her own legal issues from Trump and his team for financial fraud. While a federal judge last year dismissed one mortgage-fraud case, Trump’s housing czar Bill Pulte made criminal insurance-fraud referrals against James over rental properties she owns.
“They’re communists, so of course they will oppose this deal,” said one person close to Paramount. “In the end they will probably lose, but if they win, do you really think Warner won’t be cutting costs given what was happening before the deal?”
DALLAS--(BUSINESS WIRE)--Texas Pacific Land Corporation (NYSE: TPL) (“TPL”) today announced an agreement with Chevron U.S.A. Inc., a subsidiary of Chevron Corporation (NYSE: CVX) ( “Chevron”) to provide land and brackish water resources for Chevron’s recently announced development known as Project Kilby, involving a large-scale power generation facility Chevron is developing to support a customer data center in Reeves County, Texas.
As part of the agreement, TPL contributed surface acreage in exchange for cash consideration and the exclusive right to source aquifer-derived water for the power generation facility and other associated aspects of the project.
“This advancement of giga-watt scale power generation and data centers developed by the industry’s leading technology, energy, and industrial companies validates West Texas as a premier location for compute infrastructure,” said Ty Glover, CEO of TPL. “As the world’s largest supplier of conventional energy and a leading source of renewable energy, the Permian Basin combines critical resources with skilled talent and a supportive regulatory environment. We believe these virtues position the region to become a major hub for compute services, and TPL is well positioned to support that growth through our leading surface footprint, industry relationships, and access to energy and water resources.”
Chevron has emphasized that water stewardship and community engagement are central considerations as the project advances. TPL intends to supply brackish groundwater, helping reduce demand for shared freshwater resources and reinforcing its ongoing commitment to responsible water development in the Permian Basin. TPL also continues to advance solutions for reuse of desalinated produced water from oil and gas operations.
“This project demonstrates how large‑scale energy infrastructure can be developed responsibly in West Texas to meet the increasing demands for power and technology,” said Daniel Droog, Vice President, Power Solutions of Chevron. “By securing access to land and reliable sources for non‑potable brackish water supply, engaging openly with the community, and working closely with trusted long-term value chain partners such as TPL we aim to support economic growth while respecting the importance of water stewardship in West Texas.”
About Texas Pacific Land
Texas Pacific Land Corporation is one of the largest landowners in the State of Texas, with the majority of its ownership concentrated in the Permian Basin. The Company is not an oil and gas producer, but its surface and royalty ownership provides revenue opportunities throughout the life cycle of a well. These revenue opportunities include fixed fee payments for use of the Company’s land, revenue for sales of materials (caliche) used in the construction of infrastructure, providing sourced water and/or treated produced water, revenue from the Company’s oil and gas royalty interests, and revenue related to saltwater disposal on the Company’s land. The Company also generates revenue from pipeline, power line and utility easements, commercial leases and temporary permits principally related to a variety of land uses including, but not limited to, midstream infrastructure projects and hydrocarbon processing facilities.
Visit TPL at http://www.TexasPacific.com.
This press release contains certain statements that may include “forward-looking statements.” All statements, other than statements of historical or present facts or conditions, included herein are “forward-looking statements.” Included among “forward-looking statements” are, among other things, statements regarding TPL’s business strategy, plans and objectives. TPL believes that the expectations reflected in these “forward-looking statements” are reasonable, they are inherently uncertain and involve a number of risks and uncertainties beyond TPL’s control. In addition, assumptions may prove to be inaccurate. Actual results may differ materially from those anticipated or implied in “forward-looking statements” as a result of a variety of factors. These “forward-looking statements” speak only as of the date made, and other than as required by law, TPL undertakes no obligation to update or revise any “forward-looking statement” or provide reasons why actual results may differ, whether as a result of new information, future events or otherwise.
StorageGRID 12.1 delivers up to 12TB/s throughput and massive scale for AI workloads
SAN JOSE, Calif.--(BUSINESS WIRE)--NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today announced the release of StorageGRID 12.1, designed to help customers scale AI and other modern workloads with a federated global namespace. The new capabilities improve how data is accessed, processed, and managed across distributed environments to support AI data pipelines, data lakes, and modern object-based applications.
Organizations are contending with rapid growth in unstructured data to serve AI workloads while also managing that data across increasingly distributed hybrid environments. In its Object Storage Solutions Landscape, Q1 2026 report, Forrester notes that the rise of generative AI has pushed object storage further into an AI‑optimized data platform beyond its historical uses supporting enterprise data strategies with scalable, durable storage for unstructured data, media, and backups. The updates to NetApp StorageGRID enable organizations to leverage their object data for these emerging uses with new capabilities that simplify operations, improve performance, and reduce costs for data-intensive workloads such as AI.
“As organizations race to turn rapidly growing and distributed volumes of unstructured data into insight and action, they need infrastructure that makes data intelligent, accessible, and ready for AI,” said Sandeep Singh, Senior Vice President and General Manager, Platform at NetApp. “With StorageGRID 12.1, NetApp is extending the power of our data platform, giving customers a globally unified namespace to manage data at scale, accelerate AI and analytics workloads, and extract more value from their data wherever it lives.”
StorageGRID 12.1 enables organizations to scale AI and modern workloads across globally distributed environments with new capabilities including:
Global Federated Namespace: Customers can now operate at massive scale without rearchitecting applications or workflows with the introduction of federated namespaces. Federated namespaces enable management of multiple globally-distributed StorageGRID systems scaling up to 10 Exabytes in a single namespace. Large Performance, Efficiency, and Data Management Improvements: Helping customers reduce compute costs and improve efficiency of modern workloads, StorageGRID 12.1 delivers up to 400 percent higher throughput compared to 12.0 depending on workload and object size. With the performance enhancements, StorageGRID can now deliver up to 12 TB/s of throughput to AI Factories. Batch operations allow customers to easily execute operations on billions of objects. New capabilities enable AI agents to easily track changes to object storage buckets since the last scan, enhancing the ability to build comprehensive AI data pipelines. Expanded security and governance capabilities: Stronger controls for regulated environments help enable customers to accelerate innovation while protecting their data with multi-admin verification. Recognizing NetApp among top object storage solutions, Forrester named NetApp a Leader in The Forrester Wave™: Object Storage Solutions, Q2 2026. According to the report, "NetApp has a compelling vision of enterprise data infrastructure optimized for hybrid, multicloud, and sovereign use cases," and is "a strong fit for large enterprises managing distributed, regulated object estates that want to balance governance and hybrid consistency against the need for AI-native storage services." This is Forrester's inaugural Wave evaluation of the object storage market.
Additional Resources
StorageGRID Optimize Your Data with Modern Object Storage Forrester does not endorse any company, product, brand, or service included in its research publications and does not advise any person to select the products or services of any company or brand based on the ratings included in such publications. Information is based on the best available resources. Opinions reflect judgment at the time and are subject to change. This report is part of a broader collection of Forrester resources, including interactive models, frameworks, tools, data, and access to analyst guidance. For more information, read about Forrester’s objectivity here.
About NetApp
For more than three decades, NetApp has helped the world’s leading organizations navigate change – from the rise of enterprise storage to the intelligent era defined by data and AI. Today, NetApp is the Intelligent Data Infrastructure company, helping customers turn data into a catalyst for innovation, resilience, and growth.
At the heart of that infrastructure is the NetApp data platform – the unified, enterprise-grade, intelligent foundation that connects, protects, and activates data across every cloud, workload, and environment. Built on the proven power of NetApp ONTAP, our leading data management software and OS, and enhanced by automation through the AI Data Engine and AFX, it delivers observability, resilience, and intelligence at scale.
Disaggregated by design, the NetApp data platform separates storage, services, and control so enterprises can modernize faster, scale efficiently, and innovate without lock-in. As the only enterprise storage platform natively embedded in the world’s largest clouds, it gives organizations the freedom to run any workload anywhere with consistent performance, governance, and protection.
With NetApp, data is always ready – ready to defend against threats, ready to power AI, and ready to drive the next breakthrough. That’s why the world’s most forward-thinking enterprises trust NetApp to turn intelligence into advantage.
Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
Carvana Co. (NYSE:CVNA) may see slower retail unit growth in the second quarter, according to Jefferies analysts, though the firm maintained its Buy rating and $95 price target, citing confidence in the company's longer-term outlook.
This price target implies upside from current levels of about $65.
Jefferies' analysis, based on web-scraped data, suggests Carvana's retail unit growth eased to below 30% in recent weeks and to the low-20% range in the most recent week of June. That marks a deceleration from growth rates of 38% in April and 33% in May, as well as 40% in the first quarter.
The firm now estimates second-quarter retail unit growth of 33% year over year, assuming sales trends during the second half of June follow seasonal patterns seen last year.
That forecast is about 2% below Wall Street consensus expectations for 37% growth and would represent Carvana's first retail unit miss in 10 quarters.
Jefferies lowered its second-quarter unit and EBITDA estimates by roughly 1% to reflect the recent slowdown. However, analysts left their forecasts for the second half of 2026 and beyond unchanged, saying the softer growth could be linked to temporary constraints associated with the company's expansion efforts and infrastructure build-out.
The firm noted that inventory levels continued to increase at a mid- to high-20% annual pace throughout the quarter, although growth has moderated compared with late 2025 and early 2026. Jefferies attributed the slower inventory expansion to tougher comparisons, efforts to improve performance at certain facilities, and uneven timing of ADESA site conversions.
At the same time, pricing trends remained supportive. Jefferies wrote that Carvana's average selling prices increased by a mid-single-digit to high-single-digit percentage year over year in each week of the second quarter, even as broader used-car prices declined in April and May. The analysts also noted that lower financing rates have helped preserve affordability for customers despite higher vehicle prices.
Carvana (CVNA - Free Report) closed at $64.83 in the latest trading session, marking a -2.76% move from the prior day. This change lagged the S&P 500's daily loss of 1.44%. On the other hand, the Dow registered a loss of 0.09%, and the technology-centric Nasdaq decreased by 2.22%.
The company's shares have seen a decrease of 2.36% over the last month, surpassing the Retail-Wholesale sector's loss of 6.89% and falling behind the S&P 500's gain of 0.08%.
Analysts and investors alike will be keeping a close eye on the performance of Carvana in its upcoming earnings disclosure. The company is forecasted to report an EPS of $0.42, showcasing a 61.54% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $6.9 billion, up 42.6% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $1.58 per share and a revenue of $28.14 billion, demonstrating changes of -6.51% and +38.46%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Carvana. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Carvana is holding a Zacks Rank of #1 (Strong Buy) right now.
Looking at valuation, Carvana is presently trading at a Forward P/E ratio of 42.2. For comparison, its industry has an average Forward P/E of 16.58, which means Carvana is trading at a premium to the group.
One should further note that CVNA currently holds a PEG ratio of 11.25. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The average PEG ratio for the Internet - Commerce industry stood at 0.98 at the close of the market yesterday.
The Internet - Commerce industry is part of the Retail-Wholesale sector. At present, this industry carries a Zacks Industry Rank of 164, placing it within the bottom 33% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Integrating operations creates approximately 100 new jobs; expands selection and delivery speed for Florida customers
SARASOTA, Fla.--(BUSINESS WIRE)--Carvana (NYSE: CVNA), the industry pioneer for buying and selling cars online, today announced plans to bring Inspection and Reconditioning Center (IRC) capabilities to its existing ADESA Sarasota wholesale auction site. The integration creates additional reconditioning capacity and a new inventory pool in Carvana's national network that supports greater selection for retail customers nationwide, faster delivery speeds for Florida Gulf Coast car buyers, and a more robust offering for local wholesale customers.
"Bringing IRC capabilities to ADESA Sarasota strengthens our national network and our customer offering while creating meaningful job opportunities in the Sarasota area," said Brian Boyd, Senior Vice President of Inventory at Carvana. "We're proud to add approximately 100 jobs to the region and look forward to growing our local team as we improve selection and speed for local customers."
Carvana has already begun hiring local team members to support this move and expects the integration to create about 100 new good-paying, skilled and entry-level jobs in inspection, reconditioning, and vehicle fulfillment over time. These roles require no college degree and come with comprehensive benefits. Candidates can browse open positions and apply here.
Located in Bradenton, Florida, ADESA Sarasota has served wholesale auto auction customers for 20 years. Now the facility will also house the teams and tools that drive Carvana retail reconditioning and fulfillment. The approximately 60-acre site includes over 3,000 parking spaces and offers significant infrastructure to support IRC operations alongside ongoing wholesale auction activities.
The integration will establish a new pool of local retail inventory, giving customers access to a broader selection of vehicles with delivery options for nearby customers as soon as the same day. Wholesale buyers will benefit from enhanced on-site inspection and reconditioning capabilities, as well as ongoing access to ADESA's in-lane and digital auction services.
Carvana's proprietary software platform, CARLI, will power the site's transition to an IRC-enabled facility, supporting operational efficiency and consistency across its national reconditioning network.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be preceded by, followed by or include the words "aim," "anticipate," "believe," "estimate," "expect," "forecast," "intend," "likely," "outlook," "plan," "potential," "project," "projection," "seek," "can," "could," "may," "should," "would," "will," similar expressions, and the negatives thereof. Forward-looking statements reflect Carvana’s current expectations and projections, and include all statements that are not historical facts, including expectations regarding the expected integration of IRC capabilities at ADESA Syracuse and the anticipated benefits therefrom, our strategy, forecasted results, potential infrastructure capacity utilization, efficiency gains, the expected capabilities and performance of Carvana’s CARLI platform, future staffing needs and hiring plans, and growth opportunities. Such forward-looking statements are subject to various risks and uncertainties. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. Among these factors are risks related to: Carvana's ability to successfully integrate IRC capabilities at the ADESA Syracuse site on anticipated timelines and budgets and to realize the expected benefits thereof; Carvana's ability to utilize its available infrastructure capacity; the ability to attract, hire, train, and retain qualified personnel; the larger automotive ecosystem, including consumer demand, global supply chain challenges, vehicle pricing, and other macroeconomic issues (including with respect to the impact of tariffs on our business); our ability to effectively manage our rapid growth and maintain customer service quality, reputational integrity, and brand recognition; seasonal and other fluctuations in our operating results; our relationship with DriveTime and its affiliates; our highly competitive industry; our use of artificial intelligence; and the other risks identified under the “Risk Factors” section in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. There is no assurance that any forward-looking statements will materialize. You are cautioned not to place undue reliance on forward-looking statements, which reflect expectations only as of this date. Carvana does not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise.
About Carvana
Carvana’s mission is to change the way people buy and sell cars. Since launching in 2013, more than 4 million customers have chosen Carvana’s leading automotive e-commerce experience to shop, sell, finance, and trade in vehicles entirely online, with the convenience of delivery or local pickup as soon as the same day. Carvana’s unique offering is powered by its passionate team, differentiated national infrastructure, and purpose-built technology.
For more information, please visit Carvana.com.
About ADESA
ADESA is a leader in wholesale auto, providing comprehensive remarketing and logistics solutions that help OEMs, financial institutions, fleets, and dealers source, sell and manage cars efficiently and profitably. ADESA customers across the country enjoy access to its extensive physical auction network, robust digital offerings, and value-added services. ADESA is owned by leading online automotive retailer Carvana (NYSE: CVNA). Learn more about ADESA here.
The Retail-Wholesale group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Fossil Group (FOSL - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Retail-Wholesale sector should help us answer this question.
Fossil Group is one of 189 companies in the Retail-Wholesale group. The Retail-Wholesale group currently sits at #12 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Fossil Group is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for FOSL's full-year earnings has moved 54.5% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the most recent data, FOSL has returned 6.7% so far this year. In comparison, Retail-Wholesale companies have returned an average of -1.9%. This means that Fossil Group is performing better than its sector in terms of year-to-date returns.
Genesco (GCO - Free Report) is another Retail-Wholesale stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 36.5%.
For Genesco, the consensus EPS estimate for the current year has increased 4.7% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
To break things down more, Fossil Group belongs to the Retail - Apparel and Shoes industry, a group that includes 40 individual companies and currently sits at #83 in the Zacks Industry Rank. Stocks in this group have lost about 6.1% so far this year, so FOSL is performing better this group in terms of year-to-date returns. Genesco is also part of the same industry.
Going forward, investors interested in Retail-Wholesale stocks should continue to pay close attention to Fossil Group and Genesco as they could maintain their solid performance.
Rivian (RIVN +1.71%) has done a lot in a short period of time. Given that it is a money-losing start-up in the capital-intensive automotive sector, each step it has taken has been a make-or-break moment. So far, the company has executed very well. But the next make-or-break moment is already here, and it is a big one. The year-to-date stock decline of 22% is a sign that Wall Street is worried. There's a good reason for that concern.
What has Rivian achieved? Rivian has designed an award-winning all-electric truck. It has built a factory to produce that truck at scale. And it has produced a gross profit, selling the trucks it builds for more than it costs to build them. These are impressive achievements, and the company should be proud. However, it is still losing money, so it isn't yet a sustainable business.
Image source: Getty Images.
The next big step in that direction is already here, however, as the company is launching a mass-market electric vehicle, called the R2. Until now, Rivian's trucks have been focused on high-end customers and business customers (delivery trucks). It needs to spread its costs over more vehicles if it is going to be sustainably profitable. Notably, it is traveling the same path as Tesla (TSLA 0.07%), which is now a sustainably profitable carmaker.
Rivian: There's no way to know what happens until it happens Following in Tesla's footsteps is a good approach, but there's an important difference today: every major automaker now produces EVs. When Tesla built its business, it was basically the only EV game in town. The bar is much higher today than it was. And the drop in Rivian's stock price so far in 2026 reflects Wall Street's concern about the launch of the R2.
Today's Change
(
1.71
%) $
0.26
Current Price
$
15.14
That launch is taking place now, so the company's second-quarter earnings results won't reflect the impact of the R2. It may provide an early update on how well the new car is selling, but it will likely be another quarter before the revenues from those sales start to show up on the income statement. And even then, it will take several quarters, if not longer, to get a good read on whether or not consumers like the truck. It is a waiting game.
The R2 is big for Rivian If the R2 is well-received, Rivian could see its stock rally. If the R2 isn't well received, Rivian could have a hard time convincing Wall Street that it will ever become a sustainably profitable company. The stock would likely fall. Most investors should probably stay on the sidelines here until there's more clarity on the R2's success. This is an aggressive growth investment that only the most risk-tolerant investors should own.
Roughly a decade ago, investors who either missed Tesla's high-risk, uncertain, rapid-growth phase and high-flying valuation or didn't believe in it spent much time trying to find the "next Tesla." Then many also missed BYD's rapid rise.
Fast-forward to today, and many wonder whether Rivian Automotive (RIVN +1.61%) or Lucid Group (LCID 0.96%) could deliver lucrative returns as the electric vehicle (EV) market slowly gains traction in the U.S. market. Some investors compare the two EV makers' top-line growth.
But which of these two, young EV makers is winning the race that actually matters?
Rivian's R2. Image source: Rivian.
Top-line momentum Lucid had a bumpy beginning to its history, marred with supplier disruptions and production hiccups, sprinkled with recalls along the way. Then Lucid began smoothing out operations and put together an impressive streak of eight consecutive record-setting quarterly delivery totals. That streak ended, just falling short by a handful of vehicles in the first quarter of 2026, but the surge helped the young automaker match rival Rivian in top-line growth over the past three years.
LCID Revenue (TTM) data by YCharts
Investors have reason to believe both EV makers' top-line growth will continue, as Lucid is still accelerating the production and deliveries of its latest launch, the Gravity SUV, and Rivian is doing the same with its potentially groundbreaking R2. Lucid's and Rivian's top-line growth is certainly a story and one to keep an eye on, but really, the race that matters is gross profitability improvements. That race has certainly favored Rivian.
Today's Change
(
-0.96
%) $
-0.05
Current Price
$
5.14
Gross profitability, especially for young companies such as Lucid and Rivian, is incredibly important to investors because it measures the core efficiency of the production process. It shows you exactly how much value remains from sales after covering the direct costs of creating the product. If a young company can't make consistent progress on that aspect, there's little hope it'll ever churn out real bottom-line profits or long-term returns for investors.
Put more simply: Achieving gross profitability, or at least consistent improvement, proves to investors the company is a viable long-term investment. As you can see in the graph, Rivian is turning this race into a story of the tortoise and the hare.
LCID Gross Profit (Quarterly) data by YCharts
Despite starting from a worse position three years ago, Rivian has posted both quarterly gross profits and consistent improvements when judged by its overall trajectory and past quarterly volatility and seasonality.
And the winner is.... There's reason to believe Rivian's gross profitability is here to stay, as the recently launched R2 offers significant reductions in vehicle material costs and complexity, along with growing revenue from higher-margin software and services. The latter is why Rivian's joint venture with Volkswagen is so valuable.
Regarding the former point, Rivian's material costs for the R2 are roughly 50% lower than those for its original R1 vehicle platform, and as its scale improves, those factors combine to drastically reduce fixed and variable costs per vehicle.
Today's Change
(
1.61
%) $
0.24
Current Price
$
15.13
Both Rivian and Lucid face challenges in their own way going forward, especially considering policy changes that include removing the $7,500 federal EV tax credit, among others. Both still have to contend with a lucrative U.S. market where new-vehicle prices are continuing to rise -- currently averaging just over $50,000 -- making consumers more cautious, while the EV market is growing more slowly than originally anticipated.
That said, if you're again looking for the next Tesla, there may not be one. Investors who continue to look, however, should take top-line growth with a grain of salt and remember that gross profitability is the first of many required steps to becoming a more viable long-term investment, which increases demand for the stock and thus its valuation. Rivian is winning the important race, and Lucid has much work to do.
Rivian (NASDAQ:RIVN | RIVN Price Prediction) at $14.89 is a Hold, with fresh capital best reserved unless a broader sector panic drags the equity toward $11.50.
Robinhood Markets (HOOD 3.90%) has delivered for investors. Since the start of 2024, the stock has surged 731%, far outpacing peers such as Interactive Brokers and Charles Schwab. Robinhood has done an excellent job of expanding its customer base and consistently rolling out new offerings to increase its total asset base.
The company made headlines earlier this month when it announced it secured regulatory approval to serve as a direct underwriter for initial public offerings (IPOs). This moves Robinhood into the investment banking space, opening up an entirely new revenue stream for the company.
Image source: Getty Images.
Robinhood is taking on investment banks On the heels of Space Exploration Technologies' IPO, Robinhood announced it would build out its own investment banking and equity underwriting business. No longer will Robinhood be a passive distributor for third-party investment banks. Instead, Robinhood becomes a direct syndicate partner in IPOs, gaining control of shares at the institutional offer price and bypassing Wall Street intermediaries and gatekeepers.
Moving into equity underwriting moves Robinhood beyond its retail brokerage platform and into a full-service financial services company that aims to take on Wall Street's giants. It also builds on Robinhood's growing platform, which has added numerous offerings in recent years, including futures and index options, retirement accounts, prediction markets, stock tokens, and agentic artificial intelligence (AI) trading.
Robinhood aims to provide its customer base with early access to IPO stocks before they begin trading on public exchanges. This privilege has traditionally been reserved for institutional and high-net-worth investors. As a syndicate underwriter, Robinhood hopes to remove barriers and allow everyday users to participate in IPOs at their listing price, rather than inflated secondary-market prices.
Today's Change
(
-3.90
%) $
-4.03
Current Price
$
99.22
The move opens up a new revenue stream for Robinhood The move benefits both Robinhood users and Robinhood itself by providing a profitable, nontransactional revenue stream. The company has historically relied on payment for order flow (PFOF), which has been heavily scrutinized, and net interest income, which is sensitive to the Federal Reserve's interest rate policy. The expansion is the next step for Robinhood as it builds itself up as a formidable competitor in the financial services industry.
While the move opens Robinhood to new revenue streams, it will take time to build up its investment banking business. As part of this, the company will need to gain the trust of corporate issuers and build relationships with management teams. It is also exposed to legal risks when performing due diligence under federal and state securities laws. Finally, investment banking fees are highly volatile, and revenues could become more cyclical as a result.
Robinhood has done an excellent job of evolving from a stock-trading app to a profitable financial services operation. The company has continued to grow its customer and asset base, and the move into equity underwriting will open new revenue streams as it expands. That said, with the stock trading at 49 times forward earnings, investors are already banking on strong growth ahead.
Charles Schwab is an advertising partner of Motley Fool Money. Courtney Carlsen has positions in Interactive Brokers Group and Robinhood Markets. The Motley Fool has positions in and recommends Interactive Brokers Group. The Motley Fool recommends Charles Schwab and recommends the following options: long January 2027 $43.75 calls on Interactive Brokers Group, short January 2027 $46.25 calls on Interactive Brokers Group, and short June 2026 $97.50 calls on Charles Schwab. The Motley Fool has a disclosure policy.
Robinhood Markets (HOOD 3.90%) operates a popular investing platform where its clients buy and sell stocks, futures, options, cryptocurrency, and even contracts in the prediction markets. Its stock hit a 52-week low of $63 in March, capping off a brutal 57% decline from last year's record high of $154.
The sell-off was sparked by weakness in Robinhood's options and crypto trading businesses, which account for most of its transaction-based revenue. But the company's monthly brokerage metrics showed a recovery in those areas in May, so its stock has surged by around 65% from its March low.
While that sounds encouraging, I don't think the recovery will last. In fact, here's why I'm predicting another sharp move lower for the stock.
Image source: The Motley Fool.
Robinhood's transaction-based revenue is on shaky foundations The majority of Robinhood's revenue comes from the transaction fees it earns whenever a client buys or sells stocks, options, or cryptocurrencies. It generated $623 million in total transaction-based revenue during the first quarter of 2026 (ended March 31), which was a 20% decline from the fourth quarter of 2025 -- just three months earlier.
Options transaction revenue was the largest of four components, and it shrank by 17% to $260 million. Options contracts are financial derivatives that many of Robinhood's clients use to make risky directional bets on stocks, exchange-traded funds (ETFs), and other assets. The stock market was very unpredictable during the first quarter because of the conflict between the U.S. and Iran, which likely spooked many options traders.
Today's Change
(
-3.90
%) $
-4.03
Current Price
$
99.22
Crypto transaction revenue experienced an even sharper sequential decline of 39% during the quarter, and came in at $134 million, the lowest level since 2024. The crypto market is in the throes of a brutal sell-off right now, and while highly speculative tokens like Dogecoin have declined the most, even Bitcoin is down 50% from its all-time high. This is likely keeping many investors sidelined.
Image source: Robinhood Markets.
Robinhood reports quarterly results like every other publicly listed American company, but it also reports monthly brokerage metrics to give shareholders a more frequent update on its clients' trading activity. During May, daily active trading volume in the options segment increased for the second straight month and hit the highest level of 2026 so far. This is a sign that the company's financial results for the second quarter (ending June 30) could bring an upside surprise.
However, history suggests it probably won't be sustainable. Spikes in trading volume in speculative segments like options and crypto tend to be very short-lived, because they are not markets where clients consistently make money. Earlier this year wasn't the first time Robinhood suffered a sharp drop in transaction revenue in the options and crypto segments -- it experienced even steeper declines after the stock market and crypto bull markets of 2021 came to an end.
Robinhood's valuation leaves little room for further upside When the stock set its all-time high last October, its price-to-sales ratio (P/S) was more than 30, which was almost triple its long-term average of 11.8. That valuation simply wasn't sustainable. But even though the stock is well off its highs, its P/S is still at an elevated level of 20.8.
HOOD PS Ratio data by YCharts.
That suggests Robinhood stock would have to decline by 43% just to trade in line with its long-term average P/S of 11.8. But that isn't the worst part: Hypothetically, if the company's overall revenue shrinks during the next few quarters like it did in the first quarter, then its forward P/S might actually be higher than its current ratio, meaning the stock is actually more expensive today than it appears at face value.
Although the company had a record 27.4 million clients at the end of the first quarter, just 13.5 million were actively engaging with the platform each month, which is still 36% below its peak of 21.3 million from the second quarter of 2021. Because many of its clients engage in risky options and crypto trading -- where it's very difficult to generate consistent profits -- some will inevitably drop off over time.
As a result, I think Robinhood's revenue will continue to be incredibly lumpy and unpredictable, as it has been since the company went public in 2021. That isn't a recipe for sustained upside in its stock, especially from its current valuation.
SummaryHOOW remains a Hold due to volatility drag, NAV erosion, and lack of high-conviction near-term upside in Robinhood.HOOW's leveraged structure amplifies drawdowns and capital erosion, requiring immediate bullish moves in HOOD to offset payout shrinkage and volatility drag.While HOOD's long-term thesis has strengthened - driven by prediction markets, agentic AI trading, and premium tier growth - valuation and near-term catalysts are less compelling.Recent HOOD rally and upcoming Q2 earnings could shift momentum, but mechanical pressures, regulatory risks, and high valuations temper near-term enthusiasm for HOOW. takasuu/iStock via Getty Images
I had a Hold rating on the Roundhill HOOD WeeklyPay ETF (HOOW) in August last year. The outlook was based on a lack of immediate catalyst ahead for the underlying, Robinhood Markets, Inc. (
4.52K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
A downtrend has been apparent in Medifast (MED - Free Report) lately with too much selling pressure. The stock has declined 18.9% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.
We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.
RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.
Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.
So, by this measure, if a stock has gotten too far below its fair value just because of unwarranted selling pressure, investors may start looking for entry opportunities in the stock for benefiting from the inevitable rebound.
However, like every investing tool, RSI has its limitations, and should not be used alone for making an investment decision.
Why MED Could Bounce Back Before LongThe heavy selling of MED shares appears to be in the process of exhausting itself, as indicated by its RSI reading of 26.5. So, the trend for the stock could reverse soon for reaching the old equilibrium of supply and demand.
The RSI value is not the only factor that indicates a potential turnaround for the stock in the near term. On the fundamental side, there has been strong agreement among the sell-side analysts covering the stock in raising earnings estimates for the current year. Over the last 30 days, the consensus EPS estimate for MED has increased 1.5%. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term.
Moreover, MED currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. This is a more conclusive indication of the stock's potential turnaround in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
A logo of Blackstone is pictured in Manhattan, New York City, U.S. July 29, 2025. REUTERS/Mike Segar//File Photo Purchase Licensing Rights, opens new tab
June 23 (Reuters) - Blackstone (BX.N), opens new tab is planning to invest $30 billion in Japan's AI data centers over the next three to five years, its president and chief operating officer Jonathan Gray told Nikkei in a recent interview, the business daily reported on Tuesday.
The world's largest alternative asset manager is in discussions to develop facilities exceeding 1 gigawatt in the country, the report said, citing Gray.
Get a daily digest of breaking business news straight to your inbox with the Reuters Business newsletter. Sign up here.
Blackstone did not immediately respond to a Reuters request for comment. It also plans to accelerate its private equity investments in Japan, the company said.
Earlier this month, Blackstone had raised $13.1 billion for its Asia private equity fund, exceeding its initial target and marking its largest such fundraise in the region.
Reporting by Jasmeen Ara Shaikh in Bengaluru; Editing by Vijay Kishore
Our Standards: The Thomson Reuters Trust Principles., opens new tab
HomeMarketsPublished: June 24, 2026 at 8:11 a.m. ET
Blackstone’s decision to cap withdrawals from its flagship fund is a “feature and not a flaw” of the system, designed to “protect investors from themselves,” according to one strategist.
At the beginning of June, the New York–based investment-management company said it was limiting redemptions from its $82 billion Blackstone Private Credit Fund, known as BCRED, to 5% of shares after a rise in requests. The move came after investors in the fund tried to redeem 8% in the first quarter and 10% in the second quarter, as concerns grew over artificial intelligence’s potential to disrupt the industry as a whole.
About the Author
Nora Redmond is a MarketWatch reporter based in London.
Chipotle Mexican Grill (CMG - Free Report) closed at $30.95 in the latest trading session, marking a +1.34% move from the prior day. The stock's change was more than the S&P 500's daily loss of 1.44%. On the other hand, the Dow registered a loss of 0.09%, and the technology-centric Nasdaq decreased by 2.22%.
The stock of Mexican food chain has fallen by 7.15% in the past month, lagging the Retail-Wholesale sector's loss of 6.89% and the S&P 500's gain of 0.08%.
The investment community will be closely monitoring the performance of Chipotle Mexican Grill in its forthcoming earnings report. The company is scheduled to release its earnings on July 29, 2026. The company is expected to report EPS of $0.32, down 3.03% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $3.32 billion, showing a 8.25% escalation compared to the year-ago quarter.
CMG's full-year Zacks Consensus Estimates are calling for earnings of $1.13 per share and revenue of $12.93 billion. These results would represent year-over-year changes of -3.42% and +8.4%, respectively.
Any recent changes to analyst estimates for Chipotle Mexican Grill should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.07% higher. Chipotle Mexican Grill is currently sporting a Zacks Rank of #3 (Hold).
Looking at valuation, Chipotle Mexican Grill is presently trading at a Forward P/E ratio of 26.99. This expresses a premium compared to the average Forward P/E of 19.12 of its industry.
We can additionally observe that CMG currently boasts a PEG ratio of 1.97. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. CMG's industry had an average PEG ratio of 1.89 as of yesterday's close.
The Retail - Restaurants industry is part of the Retail-Wholesale sector. Currently, this industry holds a Zacks Industry Rank of 199, positioning it in the bottom 19% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Chipotle (CMG +1.89%) is accelerating the pace of development.
*Stock prices used were the afternoon prices of June 20, 2026. The video was published on June 22, 2026.
Parkev Tatevosian, CFA has positions in Chipotle Mexican Grill. The Motley Fool has positions in and recommends Chipotle Mexican Grill. The Motley Fool recommends the following options: short June 2026 $36 calls on Chipotle Mexican Grill. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
, /PRNewswire/ -- PBF Energy Inc. (NYSE:PBF) announced today that it will release its earnings results for the second quarter 2026 on Thursday, July 30, 2026. The company will host a conference call and webcast regarding results and other business matters on Thursday, July 30, 2026, at 8:30 a.m. ET.
The call is being webcast and can be accessed on PBF Energy's website, http://www.pbfenergy.com. The call can also be accessed by dialing (800) 549-8228 or (646) 564-2877. The audio replay will be available approximately two hours after the end of the call and will be available on the company's website.
About PBF Energy Inc.
PBF Energy Inc. (NYSE: PBF) is one of the largest independent refiners in North America, operating, through its subsidiaries, oil refineries and related facilities in California, Delaware, Louisiana, New Jersey and Ohio. Our mission is to operate our facilities in a safe, reliable and environmentally responsible manner, provide employees with a safe and rewarding workplace, become a positive influence in the communities where we do business and provide superior returns to our investors.
PBF Energy is also a 50% partner in the St. Bernard Renewables joint venture focused on the production of next generation sustainable fuels.
Contacts:
Colin Murray (investors)
[email protected]
Tel: 973.455.7578
Michael C. Karlovich (media)
[email protected]
Tel: 973.455.8981
PBF Energy (PBF - Free Report) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, PBF crossed above the 20-day moving average, suggesting a short-term bullish trend.
A well-liked tool among traders, the 20-day simple moving average offers a look back at a stock's price over a 20-day period. This is very beneficial to short-term traders, as it smooths out short-term price trends and gives more trend reversal signals than longer-term moving averages.
Similar to other SMAs, if a stock's price moves above the 20-day, the trend is considered positive, while price falling below the moving average can signal a downward trend.
Shares of PBF have been moving higher over the past four weeks, up 6.4%. Plus, the company is currently a Zacks Rank #3 (Hold) stock, suggesting that PBF could be poised for a continued surge.
Looking at PBF's earnings estimate revisions, investors will be even more convinced of the bullish uptrend. There have been 5 revisions higher for the current fiscal year compared to none lower, and the consensus estimate has moved up as well.
Investors should think about putting PBF on their watchlist given the ultra-important technical indicator and positive move in earnings estimate revisions.
On June 24, 2026, we delve into the DCF analysis for Intercontinental Exchange Inc ICE , a company that has experienced notable price performance fluctuations recently. The stock has seen a decline of 5.9% over the past week, 12.7% over the past month, 17.3% year-to-date, and a significant 25.1% over the past year.
DCF Earnings-based intrinsic value of $128.85 vs current price of $133.00 (margin of safety: -3.2%) DCF FCF-based intrinsic value of $134.64 vs current price (second opinion: fair valued with 1.2% margin of safety) GF Score™ of 86/100, indicating a high reliability of the DCF inputs What Is ICE Worth? DCF Earnings-Based Model The DCF earnings-based model for ICE utilizes a two-stage approach to estimate the intrinsic value of the stock. In the first stage, we project earnings growth over the next ten years, followed by a terminal growth phase. The assumptions used in this model are outlined in the table below:
Parameter Value Current EPS (TTM, excl. non-recurring) $7.58 10-Year Growth Rate 10.9% 10-Year Treasury Rate 4.49% Discount Rate (ceil(Treasury) + 6%) 11% Terminal Growth Rate 4% In the first stage, we expect EPS to grow at a rate of 10.9% annually for the next ten years, which is then discounted at a rate of 11%. The value derived from this growth stage is $75.43 per share. Following this growth phase, we transition into the terminal stage where growth slows to a 4% rate for the subsequent ten years, also discounted at 11%. The terminal stage value is calculated at $53.42 per share. The summary of the calculation is as follows:
Stage Description Value Growth Stage (Years 1-10) EPS growing at 10.9%, discounted at 11% $75.43 Terminal Stage (Years 11-20) 4% terminal growth, discounted at 11% $53.42 Intrinsic Value Growth + Terminal $128.85 Comparing the current price of $133.00 to the intrinsic value of $128.85 indicates that ICE is fairly valued, with a margin of safety of -3.2%. It is important to note that GuruFocus uses EPS excluding non-recurring items, as research shows that stock prices tend to correlate more closely with earnings than with free cash flow. For a detailed breakdown, visit the ICE DCF Calculator.
What Does the Free Cash Flow DCF Say? The free cash flow (FCF)-based intrinsic value for ICE is calculated at $134.64. This value provides a second opinion on the valuation of the stock. When compared to the earnings-based intrinsic value of $128.85, both models suggest that ICE is fairly valued, with the FCF model indicating a 1.2% margin of safety.
How Does GF Value™ Compare to the DCF Models? The GF Value™ for ICE stands at $165.59, offering a third perspective on the valuation of the stock. GF Value™ is GuruFocus' proprietary measure, calculated based on historical trading multiples, past business growth, and future performance estimates. While the DCF models indicate that ICE is fairly valued, the GF Value™ suggests that the stock may be undervalued, creating a divergence in valuation perspectives. For further insights, visit the GF Value™ page.
What Does ICE's GF Score™ Tell Us? The GF Score™ ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Score™ values have been found to generate higher long-term returns based on backtested data from 2006 to 2021. The current GF Score™ for ICE is 86/100, indicating strong fundamentals. The table below summarizes the key metrics:
Metric Rating GF Score™ 86/100 Financial Strength 4/10 Profitability 8/10 Growth 10/10 Valuation 8/10 Momentum 4/10 With a predictability rank of 2/5 stars, it is important to note that higher predictability ratings generally lead to more reliable DCF estimates. For more details, visit the ICE stock page.
Key Assumptions and Limitations It is crucial to recognize that DCF models are highly sensitive to the assumptions made regarding growth rates and discount rates. Stocks with low predictability ratings, such as ICE's 2/5 stars, may produce less reliable DCF estimates. Additionally, the terminal growth rate of 4% is a simplifying assumption that may not reflect future economic conditions accurately.
What This Means for Investors In synthesizing the three valuation models—DCF earnings, DCF FCF, and GF Value™—we find that ICE is fairly valued based on the DCF models, while the GF Value™ suggests a potential undervaluation. This divergence indicates that investors should consider multiple perspectives before making decisions. For the full DCF analysis, visit the ICE DCF Calculator. You can also explore the GF Value™ page, or use the GuruFocus Stock Screener to find undervalued predictable companies.
Frequently Asked Questions What is ICE's intrinsic value based on DCF?
Answer: earnings-based $128.85, FCF-based $134.64
Is ICE overvalued or undervalued?
Answer: Based on DCF models, ICE is fairly valued; however, GF Value™ suggests it may be undervalued.
How reliable is the DCF model for ICE?
Answer: The DCF model's reliability is moderate, indicated by a predictability rank of 2/5.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Qorvo (QRVO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Key Takeaways Z-Flex generated more than $480M in TCV in Q3, rising more than 60% sequentially for Zscaler.Zscaler saw ARR rise 25% YoY to over $3.5B, while remaining performance obligations grew 30% to $6.5B.Z-Flex helped large clients increase spending by adding new modules, like AI Protect and Zero Trust Branch. Zscaler Inc.’s (ZS - Free Report) Z-Flex program is emerging as an important growth driver for the company. The offering allows customers to make multi-year commitments while giving them the flexibility to activate or switch products without going through a new purchasing process. This approach is helping Zscaler increase customer spending, improve visibility and strengthen long-term relationships.
The momentum behind Z-Flex accelerated during the third quarter of fiscal 2026. Z-Flex generated more than $480 million in the total contract value (TCV) during the quarter, representing growth of more than 60% sequentially. Over the last 12 months, Zscaler delivered more than $1 billion in Z-Flex TCV with an average contract duration of four years.
The program is also encouraging broader platform adoption. Several large customers expanded their use of existing products while adding new modules, including AI Protect and Zero Trust Branch solutions. During the last earnings call, management revealed that one large financial customer increased annual spending by nearly 50%, while another enterprise customer expanded its spending by 60%.
The strong uptake of Z-Flex is contributing to Zscaler’s overall growth. During the third quarter, annual recurring revenues (ARR) rose 25% year over year to more than $3.5 billion. Remaining performance obligations increased roughly 30% to $6.5 billion, providing strong revenue visibility. Total third-quarter revenues rose 25% year over year to $850.4 million.
Management believes Z-Flex shortens sales cycles, increases upselling opportunities and improves customer retention. As enterprises continue consolidating cybersecurity vendors and adopting broader Zero Trust platforms, Z-Flex could remain a meaningful catalyst for Zscaler’s long-term growth and revenue expansion. The Zacks Consensus Estimate for Zscaler’s fiscal 2026 revenues is pegged at $3.33 billion, indicating 24.6% year-over-year growth.
How Do ZS’ Rivals Compare in Flexible Customer Contracts?Two major cybersecurity companies competing with Zscaler in long-term customer engagements are Palo Alto Networks, Inc. (PANW - Free Report) and CrowdStrike Holdings, Inc. (CRWD - Free Report) .
Palo Alto Networks has successfully pushed its platformization strategy, encouraging customers to consolidate multiple security products under one vendor. In the third quarter of fiscal 2026, the company’s next-generation security ARR jumped 60% year over year to $8.1 billion, reflecting strong customer commitment to multi-product contracts.
Palo Alto Networks’ bundled offerings across network security, cloud security and security operations help improve customer retention and expand spending over time. This strategy shares similarities with Zscaler’s Z-Flex program, which promotes broader platform adoption through multi-year agreements.
CrowdStrike has also benefited from higher customer consolidation trends. The company’s ARR rose 24% year over year to $5.5 billion in the first quarter of fiscal 2027. More customers continue adopting multiple Falcon modules, helping expand contract values and increase retention rates. CrowdStrike’s subscription-based model provides recurring revenue visibility similar to Zscaler’s long-term commitments.
While both competitors, Palo Alto Networks and CrowdStrike, focus on platform expansion, Zscaler’s Z-Flex program offers customers additional flexibility to activate or swap products during contract periods, which strengthens its upselling opportunities and long-term revenue growth.
Zscaler’s Price Performance, Valuation & EstimatesZS shares have plunged 44.8% year to date against the Zacks Security industry’s rise of 43.2%.
Zscaler YTD Price Return Performance
Image Source: Zacks Investment Research
From a valuation standpoint, ZS trades at a forward price-to-sales ratio of 5.22, significantly below the industry’s average of 15.65.
Zscaler Forward 12-Month P/S Ratio
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Zscaler’s fiscal 2026 and 2027 earnings implies year-over-year increases of 25.9% and 10.9%, respectively. Estimates for fiscal 2026 and 2027 have been revised upward over the past 30 days.
Image Source: Zacks Investment Research
Zscaler currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zscaler, Inc. (“Zscaler” or the “Company”) (NASDAQ: ZS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Zscaler and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On May 26, 2026, Zscaler reported its financial results for the third quarter of its 2026 fiscal year. Although Zscaler’s revenue and earnings exceeded expectations, the Company guided for current-quarter revenue of between $875 million to $878 million, falling short of the $879 million consensus expectation.
On this news, Zscaler’s stock price fell $58.19 per share, or 31.52%, to close at $126.41 per share on May 27, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among the rest: earnings.
The earnings figure itself is key, of course, but a beat or miss on the bottom line can sometimes be just as, if not more, important. Therefore, investors should consider paying close attention to these earnings surprises, as a big beat can help a stock climb and vice versa.
Now that we know how important earnings and earnings surprises are, it's time to show investors how to take advantage of these events to boost their returns by utilizing the Zacks Earnings ESP filter.
The Zacks Earnings ESP, ExplainedThe Zacks Earnings ESP is more formally known as the Expected Surprise Prediction, and it aims to grab the inside track on the latest analyst estimate revisions ahead of a company's report. The idea is relatively intuitive as a newer projection might be based on more complete information.
With this in mind, the Expected Surprise Prediction compares the Most Accurate Estimate (being the most recent) against the overall Zacks Consensus Estimate. The percentage difference provides the ESP figure. The system also utilizes our core Zacks Rank to provide a stronger system for identifying stocks that might beat their next quarterly earnings estimate and possibly see the stock price climb.
Bringing together a positive earnings ESP alongside a Zacks Rank #3 (Hold) or better has helped stocks report a positive earnings surprise 70% of the time. Furthermore, by using these parameters, investors have seen 28.3% annual returns on average, according to our 10 year backtest.
Stocks with a #3 (Hold) ranking, which is most stocks covered at 60%, are expected to perform in-line with the broader market. But stocks that fall into the #2 (Buy) and #1 (Strong Buy) ranking, or the top 15% and top 5% of stocks, respectively, should outperform the market. Strong Buy stocks should outperform more than any other rank.
Should You Consider Phillips 66?The final step today is to look at a stock that meets our ESP qualifications. Phillips 66 (PSX - Free Report) earns a #2 (Buy) 30 days from its next quarterly earnings release on July 24, 2026, and its Most Accurate Estimate comes in at $6.99 a share.
Phillips 66's Earnings ESP sits at +14.21%, which, as explained above, is calculated by taking the percentage difference between the $6.99 Most Accurate Estimate and the Zacks Consensus Estimate of $6.12. PSX is also part of a large group of stocks that boast a positive ESP. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
PSX is part of a big group of Oils and Energy stocks that boast a positive ESP, and investors may want to take a look at ConocoPhillips (COP - Free Report) as well.
Slated to report earnings on August 6, 2026, ConocoPhillips holds a #3 (Hold) ranking on the Zacks Rank, and its Most Accurate Estimate is $3.42 a share 43 days from its next quarterly update.
ConocoPhillips' Earnings ESP figure currently stands at +14.26% after taking the percentage difference between its Most Accurate Estimate and its Zacks Consensus Estimate of $2.99.
PSX and COP's positive ESP metrics may signal that a positive earnings surprise for both stocks is on the horizon.
Find Stocks to Buy or Sell Before They're ReportedUse the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>
Now Available, Veeva Falcon MLR Delivers Agentic MLRTM to Significantly Reduce Manual Effort and Shorten Review Cycles
, /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced it has acquired Copli, the pioneer in agentic medical, legal, and regulatory (MLR) solutions for the life sciences industry. Copli is now available as Veeva Falcon MLR, an agentic MLR solution that significantly accelerates content review with the potential to eliminate 70% or more of manual MLR labor within five years.
Veeva Falcon MLR brings agentic automation to marketing teams, MLR groups, and agencies. It executes rigorous reviews of promotional and medical materials, conducting compliance checks against approved labels and local regulations, to minimize manual effort and free reviewers for higher value work.
"Our breakthrough with agentic MLR marks a fundamental shift in commercial and medical content review and approval," said Jacob Scheel-Bech, CEO of Copli. "As part of Veeva, we can scale our vision for MLR transformation. Veeva Falcon MLR brings compliance at speed to the industry with intelligent agents that work seamlessly with Veeva PromoMats."
"The MLR process has long been a significant bottleneck in getting critical information to patients and doctors," said Emma Hyland, vice president, Veeva Commercial Content. "With Veeva Falcon MLR, our customers can speed up the entire review cycle, automating routine labor so reviewers can become strategic advisors."
To learn more about Veeva Falcon MLR register for the upcoming webinar on July 9 at 10 a.m. ET or visit FalconMLR.veeva.com.
About Veeva Systems
Veeva delivers the industry cloud for life sciences with software, AI, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva Forward-Looking Statements
This release contains forward-looking statements about the expected results and benefits from our acquisition of Copli. These statements are based on our current plans, estimates, and expectations. Acquisitions are risky, and we cannot be certain of success. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. We describe the risks and uncertainties that we believe are most relevant to our business, including risks associated with acquisitions, in our periodic SEC filings, which you can access at sec.gov.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
NASHVILLE, Tenn.--(BUSINESS WIRE)--LP Building Solutions (LP), a leading manufacturer of high-performance building products, broke ground on a new LP® SmartSide® ExpertFinish® Trim & Siding manufacturing facility today in North Branch, Minnesota. The approximately 350,000-square-foot facility will be built on a recently acquired 120-acre site. It is expected to create 125 jobs at full capacity and is slated to begin production in the first quarter of 2028.
Rocket Lab stock price has slipped in the past few weeks as investors book profits following the spectacular rally that happened before the SpaceX IPO. RKLB dropped to the key support level of $100, even after it entered the exclusive Nasdaq 100 Index. Still, there are some reasons why it will eventually rebound.
RKLB stock has retreated sharply this month, moving from a record high of $151 to slightly below $100 on Monday. This retreat happened on the day that it entered the Nasdaq 100 Index, a move that has forced ETFs tracking it to buy.
Technicals suggest that there is hope that the Rocket Lab shares will bounce back despite the major challenges. For one, it has dropped and found support at the 100-day weighted moving average (WMA).
Its lowest level this week is also along the crucial support of $100, the highest swing in January and the upper side of the cup-and-handle pattern. As such, there are signs that it has formed a break-and-retest pattern, which often leads to a continuation.
The Average Directional Index (ADX) has dropped from 43 to the current 25 and is still pointing downwards. That is a sign that the stock’s downward trend is losing momentum.
There are signs that the stock has formed a falling wedge pattern, which normally leads to a bullish breakout. Therefore, there is a likelihood that it will soon bounce back in the coming days or weeks, potentially to the year-to-date high of $151.
RKLB stock chart | Source: TradingView
The other bullish catalyst for Rocket Lab is that its business is firing on all cylinders as demand continues rising. Electron, its small orbital launch vehicle continues seeing strong demand from governments and companies.
Its Hypersonic Accelerator Suborbital Test Electron (HASTE), its variant of Electron, is also seeing strong demand from the US Department of Defense as it accelerates hypersonic missile developments.
Most importantly, the company continues to take orders for Neutron, its medium-lift launch vehicle that will carry more payloads.
The most recent financial results showed that it booked 31 missions in the first quarter, with the management seeing an inflection point of across its orbital and suborbital launches. This is important as the company received a 20-launch order valued at $190 million from the DoD. It has also become a major name in the Golden Dome project.
READ MORE: RKLB stock suffers a brutal reversal as a bullish pattern begins to take shape
Analysts expect that Rocket Lab’s revenue growth has more room to run. Yahoo Finance data shows that the annual revenue will jump by 52% this year to $915 million. It will then grow by 41% next year to $1.29 billion. If this trend continues, it will hit the $5 billion milestone in the coming years.
Rocket Lab’s other catalyst is that it plans to launch Neutron later this year, with its deployment expected to increase gradually over time. A combination of Neutron, Electron, and Haste will lead to robust revenue growth over time.
By launching Neutron, the company will now start to focus on boosting its profitability.
Still, there are some risks to the thesis. The first one is that it is common for stocks to retreat after entering a major index like the Nasdaq 100. A good example of this is Robinhood, which has dropped sharply since its entry.
The other risk is that it may enter the distribution and markdown phases of the Wyckoff Theory. These phases are usually characterized by sharp declines in prices.
Further, Rocket Lab is not a cheap company as it trades at a forward price-to-sales ratio of 67, much higher than most companies. As such, there is a risk that it may go through a valuation reset.
Rocket Lab stock is among today’s weakest performers. What’s weighing on RKLB shares? What Does Rocket Lab’s Nasdaq-100 Inclusion Mean?Rocket Lab officially joined the Nasdaq-100 on Monday, a change that forces index-tracking funds and ETFs, including Invesco QQQ, which manages over $300 billion, to own the stock. The inclusion comes after a choppy stretch for space-sector proxies following Space Exploration Technologies Corp (SpaceX) IPO day on June 12, when RKLB sold off as capital rotated toward the new listing.
Rocket Lab Shatters Records with VICTUS HAZEMeanwhile, Rocket Lab late Monday launched the U.S. Space Force’s VICTUS HAZE mission 16 hours and 42 minutes after receiving the official Notice to Launch, reducing the previous record by more than 10 hours.
The company managed all operational phases of this mission, providing an end-to-end space service that encompassed spacecraft design, component fabrication, launch, and ongoing 24/7 on-orbit management.
The deployed Pioneer spacecraft is now fully commissioned and executing orbital maneuvers. The vehicle is currently conducting Rendezvous and Proximity Operations (RPO) to track another active spacecraft in low Earth orbit.
RKLB Stock: Key Technical Levels To WatchFrom a trend perspective, RKLB is still in a bullish long-term structure—up 194.39% over the past 12 months and trading 29.7% above its 200-day SMA at $74.34—but the near-term tape is correcting. The stock is now 17.8% below its 20-day SMA ($117.27) and 8.3% below its 50-day SMA ($105.15), which frames the current move as a pullback inside a broader uptrend rather than a confirmed trend break.
Momentum is the main watch item: MACD is below its signal line and the histogram is negative, which points to upside pressure fading versus the prior upswing. In plain terms, MACD compares faster and slower trend momentum, and being below the signal line often means rallies can stall until buyers regain control.
Key Resistance: $99.50 — a nearby pivot area where rebounds can stall, sitting just under the psychologically important $100 level. How Rocket Lab Compares to Industrials TodayRKLB is underperforming Industrials today by about 2.22 percentage points (down 3.97% vs. the sector down 1.75%), which suggests the move isn’t just "sector beta" and may reflect stock-specific positioning around the index rebalance. Industrials is also having a rough session overall, ranking 10 out of 11 sectors, only ahead of Materials, while Technology is the biggest drag at down 3.78%.
The move mirrors broader pressure in growth and "story" equities, with the Nasdaq 100 down about 0.6% in the same risk-off tape that saw Alphabet tumble more than 6%. That kind of megacap-led de-risking often spills into space and defense proxies, providing a benchmark for Rocket Lab because the stock trades like a high-beta growth name when liquidity tightens.
Zooming out, the sector trend has been constructive despite today’s dip, with Industrials up 2.49% over the past 30 days and up 8.20% over the past 90 days. That backdrop matters because it implies RKLB’s longer-term bid has been supported by a favorable tape for cyclicals, but today’s underperformance highlights that the stock’s near-term path is being driven more by flows and momentum than by broad sector strength.
What Is Rocket Lab Corporation and Its Business Model?Rocket Lab is a space company that builds rockets and spacecraft, offering end-to-end mission services for civil, defense and commercial customers. It designs and manufactures the Electron and Neutron launch vehicles and the Photon satellite platform, with operations spanning Launch Services and Space Systems.
That business mix is why Nasdaq-100 inclusion is a meaningful headline: index membership can increase passive ownership and daily liquidity for a company that sits at the intersection of aerospace manufacturing and "new space" growth.
Electron’s track record delivering satellites to orbit across national security, scientific research and Earth-observation use cases helps explain why investors often treat the stock as a liquid proxy for broader space-industry sentiment.
RKLB Stock Price Movement on TuesdayRKLB Stock Price Activity: Rocket Lab shares were down 4.00% at $96.28 at the time of publication on Tuesday, according to Benzinga Pro data.
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs
The space industry is in the middle of a transformation. For years, investors focused on launch providers, treating rocket launches as the primary source of value. That model is changing.
Governments increasingly want companies that can build satellites, launch them, operate them, and respond quickly when national security demands it. The winners may not be the companies with the biggest rockets, but those that can provide complete mission solutions. That’s why Rocket Lab‘s (NASDAQ:RKLB | RKLB Price Prediction) latest Victus Haze mission may prove more important than the launch itself. For investors, it signals that Rocket Lab is evolving into something much larger than a small launch company.
Victus Haze Was About More Than a Rocket Launch According to Rocket Lab, the company launched the Victus Haze mission just 16 hours and 42 minutes after receiving a launch order from the U.S. Space Force. That set a new record for the military’s Tactically Responsive Space (TacRS) program.
On the surface, that sounds like a simple operational achievement. In reality, it demonstrated capabilities that few competitors can match.
What makes Victus Haze unique is that Rocket Lab served as the prime contractor. The company didn’t just launch the mission. It also built the satellite, integrated the payload, conducted mission planning, and now operates the spacecraft in orbit.
Here’s what Rocket Lab controlled during the mission:
Capability Rocket Lab Role Launch Vehicle Electron rocket Satellite Platform Pioneer spacecraft Mission Operations In-house Spacecraft Components In-house systems and subsystems Launch Execution In-house That level of vertical integration resembles traditional aerospace contractors more than a standalone launch provider.
The Defense Opportunity Is Now Much Larger The launch itself won’t materially change Rocket Lab’s financial results. The U.S. Space Force contract was worth approximately $32 million. In comparison Rocket Lab generated $601.8 million in revenue during 2025. A single $32 million contract is helpful, but it is not transformational. The opportunity comes from what Victus Haze proves.
The Pentagon increasingly wants responsive space capabilities that can deploy assets within days or even hours. As geopolitical tensions rise, governments need the ability to replace satellites, inspect spacecraft, and respond to threats quickly. Victus Haze demonstrated that Rocket Lab can provide all of those services under one roof.
That potentially positions the company for future contracts involving:
Space domain awareness Military satellite production Responsive launch services On-orbit inspection missions National security space operations Those markets are far larger than Rocket Lab’s traditional small-launch business.
Investors Should View Rocket Lab Differently Today For years, critics argued that launch alone would never be a large enough market to justify premium valuations across the space sector. Surprisingly, Rocket Lab appears to agree.
The company has spent the past several years building spacecraft systems, acquiring satellite component manufacturers, and expanding beyond launch services. Victus Haze provides tangible evidence that those investments are paying off.
Compare Rocket Lab to many smaller launch competitors and the distinction becomes clear. Most can sell a launch. Rocket Lab can increasingly sell an entire mission. That creates multiple revenue streams while reducing dependence on launch frequency alone.
Granted, execution risk remains. Rocket Lab still needs to prove that these defense opportunities translate into recurring contracts and growing cash flow. The company is also investing heavily in its larger Neutron rocket program, which carries development risk.
That said, Victus Haze reduced one important uncertainty: whether Rocket Lab’s broader aerospace strategy actually works. The answer appears to be yes.
Key Takeaway In short, Victus Haze is not important because it generated a $32 million contract. It matters because it demonstrated that Rocket Lab can function as a full-service aerospace and defense contractor. The mission showcased rapid launch, satellite manufacturing, mission operations, and spacecraft management in a single package.
For long-term investors, that changes the investment thesis. Rocket Lab is no longer just competing for launch contracts. It is positioning itself to compete for larger defense and space systems programs that could generate recurring revenue for years. Ultimately, Victus Haze may be remembered less as a launch and more as the moment Rocket Lab proved its business model extends far beyond the rocket itself.
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- SueWallSt reminds purchasers of Erasca, Inc. (NASDAQ: ERAS) securities of a pending securities class action.
THE CASE: A class action seeks to recover damages for investors who purchased ERAS securities between January 14, 2025 and April 26, 2026.
YOUR OPTIONS: You may be entitled to compensation without payment of any out-of-pocket fees. Find out if you qualify to recover your per-share losses or contact Joseph E. Levi, Esq. at [email protected] or (888) SueWallSt.
From a closing price of $21.49 on April 24, 2026, Erasca shares collapsed to $9.90 by the close of trading on April 28, 2026. That $11.59 per-share decline, representing a 53.9% loss of value, followed two corrective disclosures that stripped away what the lawsuit maintains was artificial inflation built on misleading preclinical comparisons and undisclosed safety and intellectual property risks. The last day to move for lead plaintiff is August 10, 2026.
The April 27, 2026 Pre-Market Disclosure
Before markets opened on April 27, 2026, Erasca filed a Form 8-K disclosing that Revolution Medicines had sent a letter alleging ERAS-0015 infringes U.S. Patent No. 12,409,225 and involves trade secret misappropriation. RevMed further alleged that Erasca had made "deceptive and untrue comparative statements" about ERAS-0015 versus RMC-6236. Shares fell from $21.49 to close at $19.15 that day, a decline of approximately $2.34 per share (10.9%).
The April 27, 2026 Post-Market Disclosure
After the close on the same day, Erasca filed a second Form 8-K reporting preliminary Phase 1 clinical data. That filing disclosed a patient death classified as a Grade 3 treatment-related adverse event of pneumonitis that progressed to Grade 5. The filing also conceded that all comparisons between ERAS-0015 and RMC-6236 were based on cross-study analyses, were "not based on any head-to-head clinical trials," and were "inherently limited." The next morning, shares opened at $10.51 and closed at $9.90, an additional decline of $9.25 per share (48.3%) from the prior close.
Alleged Investor Damages and Loss Causation
The lawsuit maintains that throughout the class period, the market price of ERAS common stock was artificially inflated by statements promoting ERAS-0015's alleged superiority over RevMed's RMC-6236. The complaint asserts the following sequence quantifies investor harm:
Erasca repeatedly claimed ERAS-0015 achieved "comparable antitumor activity to RMC-6236 at 1/10th of the dose" and demonstrated "8-21-fold higher binding affinity to cyclophilin A"These claims were presented at major investor conferences and in SEC filings without disclosing that comparisons were cross-study analyses rather than head-to-head trialsDefendants raised approximately $258.8 million in a January 2026 stock offering while these allegedly misleading comparisons were outstandingWhen the patent infringement letter and clinical safety data were disclosed on April 27-28, 2026, the artificial inflation was removed in two stages totaling $11.59 per shareThe combined decline of 53.9% reflected the market repricing ERAS shares to account for previously concealed patent, trade secret, and clinical safety risks
"When companies fail to disclose material information, shareholders may suffer significant losses. The two-stage correction in Erasca's stock price on April 27 and 28 quantifies the gap between what investors were told about ERAS-0015 and what was actually happening." -- Joseph E. Levi, Esq.
Join the ERAS recovery action or call Joseph E. Levi, Esq. at (888) SueWallSt.
ABOUT SUEWALLST -- Over the past 20 years, SueWallSt has secured hundreds of millions of dollars for aggrieved shareholders. The firm has extensive expertise in complex securities litigation and a team of over 70 employees. For seven consecutive years, SueWallSt has ranked in ISS Securities Class Action Services' Top 50 Report.
Frequently Asked Questions About the ERAS Lawsuit
Q: How much did ERAS stock drop? A: Shares fell approximately 53.9%, a decline of $11.59 per share, after Erasca disclosed a patent infringement letter from Revolution Medicines and a patient death in Phase 1 trials on April 27-28, 2026. Investors who purchased shares during the class period at artificially inflated prices may be entitled to compensation.
Q: What is the ERAS lead plaintiff deadline? A: The deadline to apply for lead plaintiff appointment is August 10, 2026. This deadline applies only to investors seeking to serve as lead plaintiff. Class members who do not apply may still participate in any recovery without taking action before this date.
Q: What if I already sold my ERAS shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.
Q: What do ERAS investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact SueWallSt for a free, no-obligation evaluation at [email protected] or (888) SueWallSt. No immediate action is required to remain eligible as a class member.
Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. You submit a claim form to receive your portion of recovery.
Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Q: What court was the ERAS class action filed in? A: The case was filed in the United States District Court for the Southern District of California, governed by the Private Securities Litigation Reform Act of 1995.
